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ABSTRACT 
Talin, a protein localized primarily in cell-matrix type adherens junctions, is involved in 
linking the cytoskeleton to the cell membrane. The major objectives of my study were to (1) 
determine the structural basis for the effect of pH and ionic strength on the direct talin-actin 
interaction, (2) examine the effects of other factors, such as specific phospholipids, on the 
talin-actin interaction, and (3) compare abilities of human platelet and avian smooth muscle 
talins to interact with actin. Negative staining results showed that at pH 6.4 and low ionic 
strength, talin extensively crosslinked actin filaments into both tight networks and bundles. 
Some of the bundles consisted of parallel actin filaments with an interfilament spacing of 
-13 nm, and talin crossbridges spaced at ~ 36 nm intervals along the actin bundles. As pH 
and/or ionic strength was increased, talin's actin bundling activity was decreased first, then 
its networking activity. Chemical crosslinking indicated that talin was present primarily as a 
dimer of two ~ 225 kDa subunits under all ionic conditions tested. Talin crosslinked actin 
filaments into networks and bundles after only five minutes of actin polymerization, with no 
evidence of shorter actin filaments formed in comparison to actin controls. Talin also 
crosslinked preformed actin filaments as well as it did actin filaments polymerized in its 
presence. The ~ 190 kDa talin fragment was able to crosslink actin filaments into networks 
and bundles, but required a slightly lower pH than did intact talin. 
The phosphoinositides, PIPj, PIP, or PI, but not ff 3 or the phosphoglycerides, PS or PC, 
greatly inhibited the ability of talin to crosslink actin filaments. The phosphoinositides bound 
talin to form talin/phosphoinositide complexes, which prevented talin from effectively 
V 
interacting with actin filaments. The detergent Triton X-100 or divalent cations, such as 
Ca^^, decreased the effect of the phosphoinositides on the talin-actin interaction. 
Cosedimentation assays, low shear viscometry, and negative staining showed that 
platelet talin interacted with actin in a fashion similar to that of smooth muscle talin. 
However, some differences were noted between the two talins, with platelet talin exhibiting 
lower actin crosslinking activity. 
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INTRODUCTION 
Dissertation Organization 
The body of this dissertation consists of three papers that have been or will be submitted 
for publication, and one additional chapter. The additional chapter, which follows the first 
paper, contains my results that will be included in two papers being prepared for submission 
to The Journal of Biological Chemistry by Dr. Jean Schmidt, and on which I am a coauthor. 
I was responsible for nearly all of the experiments described in this dissertation. Jean 
Schmidt prepared some of the talin and actin used in the research of the first two chapters 
and she prepared the 190 kDa talin fragment that I used in some experiments. The three 
papers and the extra chapter are preceded by this Introduction, which includes a Literature 
Review, and will be followed by an Overall Summary chapter. The references cited in the 
Introduction and Overall Summary are listed in a Literature Cited chapter at the end of the 
dissertation. 
Literature Review 
Actin-membrane attachment sites 
The interaction between the actin-based cytoskeleton and the plasma membrane is 
important in controlling cell shape, stabilizing attachments to other cells and to the substrate, 
regulating cell migration, and responding to growth factors and other external stimuli (Niggli 
and Burger, 1987; Luna and Hitt, 1992; Clark and Brugge, 1995). This diversity of cellular 
functions is regulated by several different biochemical mechanisms that mediate the 
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interactions between the plasma membrane and the cytoskeleton (for reviews see Luna and 
Hitt, 1992; Simon and Burridge, 1994). There are four major families of receptors on the 
cell membrane that mediate cell adhesion to other cells or to extracellular matrix; (1) 
cadherins; (2) members of the Ig superfamily; (3) selectins; and (4) integrins. The first three 
families primarily mediate cell-cell interactions, whereas the integrins are primarily involved 
in attachment of the cell to the substratum (Luna and Hitt, 1992; Hynes, 1994; Rosales et al., 
1995). The cytoplasmic domains of these transmembrane receptors also may be involved in 
linking actin filaments to the cell membrane. The attachment of the cytoskeleton to the cell 
membrane has been fairly well-described in the erythrocyte, but much less is known about 
the proteins involved in this linkage in most other cells (Carraway and Carraway, 1989; Luna 
and Hitt, 1992). In the erythrocyte, the cytoskeleton consists of a meshwork of short actin 
filaments that are connected to the membrane via a multi-protein link involving actin, 
spectrin, protein 4.1, ankyrin, band 3 (the anion exchanger), and glycophorin C (Luna and 
Hitt, 1992), 
In resting platelets, ABP-280 (filamin) is believed to play a major role in forming a 
cytoskeletal meshwork, similar to the one found in erythrocytes, by binding directly to GP 
Ib-IX, a transmembrane glycoprotein complex, and to actin filaments, even though spectrin 
and associated proteins also are present (Luna and Hitt, 1992). 
In skeletal muscle cells, dystrophin, a 427 kDa member of the spectrin superfamily, has 
been shown to link F-actin to a specific set of glycoproteins present at or in the plasma 
membrane at myotendinous and neuromuscular junctions and at cosiameric sites (Luna and 
Hitt, 1992; Campbell, 1995). There also is a set of proteins, which includes talin, vinculin, a-
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actinin, and filamin, which is thought to link actin filaments to the cell membrane via 
integrins at or near these sites, and components of the spectrin-based system are present as 
well (Luna and Hitt, 1992; Simon and Burridge, 1994; McDonald et al., 1995). 
In cultured cells, the cell-matrix attachment sites are known as focal adhesions, focal 
contacts, or adhesion plaques (Burridge et al., 1988). There are several structures found in 
living tissues that appear to be homologous with focal adhesions, including the membrane-
associated dense bodies of smooth muscle, the myotendinous junctions of skeletal muscle, 
and the adhesions made by activated platelets (Simon et al., 1991). In these areas, actin 
filaments are anchored to the cytoplasmic face of the plasma membrane at the sites where the 
cell interacts directly with the extracellular matrix, primarily through the integrins. Integrins 
are transmembrane, heterodimeric proteins composed of a and P subunits (Clark and 
Brugge, 1995). The P subunits are highly conserved while the a subunits are more varied. 
Cells express specific integrins with specific a p combinations on their surface, which enable 
them to bind selectively to different extracellular matrix components (Albelda and Buck, 
1990; Juliano and Haskill, 1993; Hynes, 1994). The cytoplasmic domain of integrin can bind 
to talin (Horwitz et al., 1986) and to a-actinin (Otey et al., 1990) each of which, in turn, 
may bind to actin filaments and thereby link them directly and/or indirectly to the plasma 
membrane (Luna and Hitt, 1992; Simon and Burridge, 1994). The redundancy of the 
membrane-cytoskeleton interactions at the cell-matrix attachment sites might enable cells to 
respond to different external stimulation. 
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Talin 
Considerable interest has been directed towards understanding the proteins involved in 
linking actin filaments to the plasma membrane at adhesion plaques. As a result, a number of 
the molecular components, including talin and vinculin, have been identified (Geiger, 1983; 
Niggli and Burger, 1987; Lo and Chen, 1994). In cultured fibroblasts, talin has been 
localized by immunofluorescence in adhesion plaques, in the ruffling membranes and leading 
lamellae of the cell periphery, and in fibrillar patterns that align with microfilament bundles 
and/or with surface fibronectin (Burridge and Connell 1983a). Since then, talin has been 
found to be present primarily at the cytoplasmic face of a variety of cell-matrix junctions 
such as membrane-associated dense bodies in smooth muscle (Volberg et al., 1986), 
myotendinous junctions (Tidball et al., 1986), neuromuscular junctions (Sealock et al., 
1986), and costameres in striated muscle (Belkin et al., 1986; Niggli and Burger, 1987). In 
general, talin is found where integrins are found, which is typically at regions of cell-matrix 
association (Beckerle and Yeh, 1990). Talin is absent from cell-cell junctions, such as 
zonulae adherens in epithelial cells (Geiger et al., 198S), even though other proteins that 
colocalize with talin at cell-matrix attachment sites, such as vinculin, a-actinin, and actin, 
can also be found at cell-cell attachment sites. These cellular locations suggest that talin 
could function either in the attachment of microfilaments to the plasma membrane or in the 
organization of microfilaments close to membrane attachment sites (Burridge and Connell, 
1983a; Simon and Burridge, 1994). 
Talin was discovered in 1982 (Burridge et al., 1982), was first purified from chicken 
gizzard by Burridge and Connell (1983b), and characterized later by Molony et al. (1987). 
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Talin is a high molecular weight protein that migrates with an apparent molecular mass of 
225 kDa by SDS-PAGE. Electron microscope observations of rotary shadowed preparations 
showed that talin is a spherical protein at low ionic strength, but unfolds to become an 
elongated molecule with an average length of 60 nm at approximately physiological 
conditions or at higher ionic strength (Molony et al., 1987). Molony et al. (1987) also 
reported that talin is monomeric at concentrations less than 0.72 mg/ml, but exhibits the 
ability to self-associate into dimers at higher protein concentrations. More recent studies, 
however, have suggested that smooth muscle talin also is present as a dimer at lower 
concentration (0.5 mg/ml) (Muguruma et al., 1992). It has been speculated that the ability of 
talin to form dimers (i.e., to self-aggregate) is relevant to its function, such as cross-linking 
two structures (Molony et al., 1987). 
At about the time talin was discovered, a protein called P235 (molecular mass of ~ 235 
kDa by SDS-PAGE) that accounts for 3-8 % of total platelet protein was isolated from 
human platelets by Collier and Wang (1982). It is now well established that P235 
corresponds to the platelet form of talin as shown by immunological crossreactivity, similar 
biophysical characteristics and one-dimensional peptide maps, and an ability to interact with 
vinculin (O'Halloran et al., 1985; Beckerle et al., 1986). Talin is now the commonly used 
name for the protein. The molecular structure of platelet talin has recently been studied using 
a variety of methods including rotary shadowing, analytical ultracentrifugation, and chemical 
crosslinking (Goldmann, et al., 1994). The results of that study showed that native platelet 
talin can exist as a dumbbell-shaped antiparallel homodimer with an average length of ~ 51 
nm even at relatively low concentrations (0.1-0.4 mg/ml). 
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More information on the molecular structure of talin became known when murine talin 
was cloned and sequenced (Rees et al., 1990). The cDNA derived primary structure of talin 
can be considered as two domains. The first N-terminal 600 residues are highly polar (28% 
charged residues) and show no internal homologies, whereas the last 1,900 residues are 
highly enriched in alanine (18%), poor in aromatic residues (2%), and show apparent internal 
homologies (McLachlan et al., 1994). The C-terminal 60 residues are highly charged (>30%) 
(Rees et al., 1990). Secondary protein structure predictions suggest a high content of a-
helix (McLachlan et al., 1994), consistent with the high a-helix content measured for talin (~ 
80%) (Molony et al., 1987). The molecular mass of murine talin estimated from the cDNA 
sequence is 269,854 Da, which is larger than its apparent molecular weight determined by 
SDS-PAGE. This discrepancy is likely to be a consequence of the unusual amino acid 
composition, secondary structure of talin (Rees et al., 1990), and/or post-translational 
modifications of talin, such as glycosylation (Hagmann et al., 1992). The amino acid 
sequence of the large - 190-200 kDa C-terminal tail region, which contains the binding sites 
for vinculin, integrin and actin (Simon and Burridge, 1994), shows a strong but irregular 
pattern of repeats as analyzed by Fourier methods (McLachlan, et al., 1994). There are 
between 50 and 65 copies of this motif in the C-terminal tail region, which are likely to be 
short a-helical segments (McLachlan, et al., 1994). Proline residues often occur between the 
motifs. Even though talin does not share sequence homology with other proteins in this 
region, the series of short helical segments are somewhat analogous to those seen in proteins 
such as spectrin, a-actinin and dystrophin (McLachlan, et al., 1994), which belong to a 
group of actin-crosslinking proteins. A 200-220 amino acid segment from the N-terminal 
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region of taiin shares homology with an N-terminal segment of proteins from the band 4.1 
family (Rees et al., 1990), including band 4.1, which helps link the spectrin-actin 
cytoskeleton of erythrocytes to the plasma membrane (Luna and Hitt, 1992), ezrin, which is 
clearly localized in a submembranous region in the brush border of intestinal epithelial cells, 
moesin (Lankes and Furthmayr, 1991), and a protein-tyrosine phosphatase-related protein 
termed PTPHl (Yang and Tonks, 1991). It has been suggested that the homologous regions 
in these proteins are involved in their binding to the cell membrane (Rees et al., 1990; Yang 
and Tonks 1991). 
To study the in vivo function of talin in cultured cells, talin was inactivated by 
microinjection of antibodies against talin into fibroblasts (Nuckolls et al., 1992). The results 
of that study showed that the effect of the injected anti-talin antibodies on cell spreading was 
dependent upon how recently the fibroblasts had been plated. Cells that were in the progress 
of spreading on a fibronectin substratum, and which had newly developed focal adhesions, 
were induced to round up and to disassemble many of the adhesions. However, in cells that 
had been allowed to spread completely before they were microinjected with anti-talin 
antibody, focal adhesions remained intact, and the morphology of the cells was not affected. 
These results indicate that talin is essential for the spreading and migration of fibroblasts on 
fibronectin, as well as for the development and initial maintenance of focal adhesions on this 
substratum (Nuckolls et al., 1992). Recent studies, in which talin was down regulated by an 
antisense RNA strategy in Hela cells, demonstrated that talin plays a central role in 
establishment of cell-matrix contacts (Albiges-Rizo et al., 1995). 
Post-translational modifications of talin, such as proteolysis, may have physiological 
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significance relative to structural changes that a cell undergoes (Beckerle and Yeh, 1990). 
Talin can be proteolyzed by a variety of proteases, including calpain, into two prominent 
proteolytic fragments, one of 47 kDa consisting of residues 1-434 (the N-terminus of talin) 
and one of ~ 190-200 kDa containing residues 435-2541 (the C-terminus of talin) 
(OHalloran et al., 1985; Beckerle et al., 1986; Rees et al., 1990). Calcium-dependent 
proteolytic cleavage of talin occurs in vivo when activated platelets aggregate with each 
other (Fox et al., 1985). Interestingly, the calcium-dependent protease type II (CDP-II or m-
calpain) has been shown to colocalize with talin in adhesion plaques of cultured cells 
(Beckerle et al., 1987). This implicates involvement of proteolysis in platelet activation and 
clot formation. However, there has been no clear evidence demonstrating a relationship 
between proteolysis of talin and platelet function (Wencel-Drake et al., 1991). The function 
of talin's two proteolytic fragments was studied by microinjection and indirect 
immunofluorescence (Nuckolls et al., 1990). It was shown that the large talin fragment 
(-190 kDa) was incorporated quickly into focal contacts and zonulae adherentes, where it 
remaned stable for at least 14 hours. The small fragment (-47 kDa) associated with focal 
adhesions of the fibroblasts, but was also found distributed in the cytoplasm and the nucleus. 
In the same set of experiments, intact talin was localized to focal contacts, but was excluded 
from the zonulae adherentes, which are cell-cell type adherens junctions (Nuckolls et al., 
1990). These experiments suggest that talin has at least two sites that contribute to its 
location in focal adhesions, one in the N-terminal domain and one in the C-terminal domain. 
In resting platelets, talin is distributed throughout the cytoplasm. However, upon activation 
by thrombin, talin becomes translocated to the submembrane areas. This translocation 
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appeared to be accompanied by the proteolytic cleavage by calpain (Beckerle et al., 1989). 
One of the objectives of my Ph.D. research was to understand the effect of proteolysis of 
talin on its ability to interact with actin filaments. 
Talin can be phosphorylated at multiple sites on serine, threonine, and tyrosine residues. 
It is an in vitro substrate for purified protein kinase C at serine and threonine residues 
(Litchfield and Ball, 1986). When chicken embryo fibroblasts were exposed to the tumor-
promoting phorbol ester, 12-myristate 13 acetate, which augments protein kinase C activity, 
phosphorylation on serine and threonine residues of talin increased three fold (Beckerle, 
1990). The phosphorylation sites are located mainly on the 47 kDa talin fragment (Beckerle, 
1990). A recent study showed that the 47 kDa fragment of talin also is a substrate for 
protein kinase P, which is a protein kinase that exhibits phospholipid-stimulation in the 
presence of Mn^^ (Simons and Elias, 1993). The biological significance of talin 
phosphorylation remains unknown. In BS-C-1 cells, a tumor promoter-induced increase in 
talin phosphorylation was correlated with a dramatic loss in the integrity of focal contacts 
and organized actin filament arrays (Turner et al., 1989). In chicken embryo fibroblasts, a 
similar increase in talin phosphorylation did not result in a detectable loss of established 
adhesion plaques or stress fibers; however, in this case, the tumor promoter did induce a loss 
of talin-rich focal contact precursors (Beckerle, 1990). 
Viral transformation can also induce dramatic changes in the organization of the 
cytoskeleton and adhesion plaques. Certain oncogene tyrosine kinases, such as pp60^''", are 
localized at adhesion plaques (reviewed in Kellie, 1988). A number of adhesion plaque 
proteins, including talin and integrin, are phosphorylated on tyrosine residues by ppdO"""* in 
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Rous Sarcoma Virus (RSV) infected cells (Pasquale et al., 1986; DoClue and Martin, 1987), 
but talin phosphorylation is not strictly correlated with the development of the transformed 
morphology in RSV infected cells (DoClue and Martin, 1987). Interestingly, phosphorylated 
integrin isolated from RSV-transformed cells fails to bind talin in equilibrium gel filtration 
assays (Buck and Horwitz, 1987). This suggests that modulation of the phosphorylation 
state of integrin can affect its ability to interact with talin and, thus, may be in part 
responsible for the transformed phenotype (Beckerle and Yeh, 1990). 
The interaction of interleukin 1 p and its receptor, which is primarily localized at focal 
adhesions, has been shown to induce rapid phosphorylation and redistribution of talin, which 
was accompanied by a simultaneous disorganization of the cytoskeleton (Quamstorm et al., 
1991). This suggests that the action of interleukin on fibroblasts may be partially mediated 
by direct phosphorylation of talin via activation of a protein serine/threonine kinase, which 
leads to changes in its interactions with transmembrane linkage proteins and the cytoskeleton 
(Quamstorm et al., 1991). An interaction between talin and actin filaments has been 
identified (Muguruma et al, 1990, Kaufmann et al., 1991, Schmidt et al., 1993) and, 
therefore, post-translational modifications of talin may also have an effect on this important 
interaction. 
As discussed earlier, in general, cell-matrix adhesion plaques in different tissues all 
appear to contain the same set of cytoskeletal proteins, e.g., actin, talin, vinculin, a-actinin, 
filamin, integrin (reviewed in Geiger 1983; Niggli and Burger, 1987; Rosales et al., 1995), 
which may be due to the similarity of cytoplasmic domains of the various integrins that are 
located at these sites (Simon et al., 1991). It is likely, therefore, that the interactions between 
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talin and other actin-membrane attachment site proteins play an important role in events that 
occur at these sites. Talin has so far been shown to interact in vitro with vinculin, 
metavinculin, integrin, and actin (reviewed in Simon et al., 1991). Recently, talin has also 
been shown to interact in vitro with dystrophin (Senter et al., 1993) and focal adhesion 
kinase (FAK) (Chen et al., 1995). 
Vinculin has a calculated molecular mass of 117 kDa by cDNA sequence analysis (Coutu 
and Craig, 1988; Price et al., 1989). The sequence of vinculin shows a remarkable division of 
the molecule into an acidic (pi -5 .4) N-terminal domain of about 90 kDa separated from an 
extremely basic (pi ~ 9.7) C-terminal domain of about 25 kDa by a proline-rich stretch of 
about 50 amino acids. It is another protein localized mainly at adhesion plaques and has been 
shown to interact with talin in vitro with a moderately high affinity (Kj of -10 * M) by a 
number of techniques, including sucrose density gradient centrifugation, gel filtration, co-
immunoprecipitation, and gel overlay methods (Otto, 1983; Burridge and Mangeat, 1984; 
Beckerle and Yeh, 1990). Vinculin can be digested with V8 protease between residues 837-
879 to generate two major fragments of approximately 90 kDa (N-terminus) and 30 kDa (C-
terminus). The talin binding sites were localized to the 90 kDa vinculin fragment (Groesch 
and Otto, 1989; Jones et al., 1989), and the affinity of the 90 kDa domain for talin is about 
3-fold higher than that of intact vinculin (Groesch and Otto, 1989). The latter result recently 
has been attributed to the intramolecular interaction of the 90 kDa and the 30 kDa fragments 
of vinculin molecules (Johnson and Craig, 1994). Other studies have shown that the N-
temiinal 258 amino acids of the vinculin molecule are required to form a functional talin 
binding domain (GHlmore et al., 1992). The vinculin binding site on talin has been localized 
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to the large 190 kDa talin fragment, which contains the C-terminal 435-2541 residues (Rees 
et al., 1990) and which can be generated by a variety of proteases including calcium-
dependent protease (calpain) (OUalloran and Burridge, 1986). Lee et al. (1992) later 
showed that there are two vinculin binding sites on talin, both located in the large 190 kDa 
portion of the molecule. One was located between residues 1653-1848. A second was 
located between residues 483 and 1652. An interaction between talin and metavinculin has 
also been shown by the gel overlay method (Burridge and Mangeat, 1984). Vinculin and 
metavinculin, a highly homologous 152 kDa protein, are derived from a single gene by 
alternative splicing of a 207-base pair exon unique to metavinculin (Byrne et al., 1992). 
Thus, the interaction between talin and metavinculin would be expected. 
Integrins are a family of transmembrane glycoproteins, which are major cell surface 
receptors for various extracellular matrix proteins. They are heterodimeric proteins 
composed of a and P subunits (Albelda and Buck, 1990; Simon and Burridge, 1994; 
Rosales et al., 1995). Integrins can be divided into groups based on their P subunit. The P 
subunits of various cell surface receptors are highly homologous with each other and so, too, 
are the a subunits; however, the a and P subunits of a given integrin are not closely related. 
The various combinations of a and P subunits allow integrins to recognize a wide variety of 
ligands (Hynes, 1994; Clark and Brugge, 1995), The large extracellular domains of the 
integrins are responsible for ligand binding, and the relatively short cytoplasmic domain of 
the p subunit often interacts with cytoskeletal proteins (Hynes 1992; Simon and Burridge, 
1994). The association of talin with integrins of the p, class exhibits a low affinity interaction 
with a Kj of -10"^ M (Horwitz et al., 1986). These investigators also reported that the talin-
integrin complex did not appear to affect either the ability of talin to bind vinculin or the 
ability of integrin to bind fibronectin. The native integrin heterodimer was required for talin 
binding (Buck et al., 1986). So far, the interaction in vitro between talin and integrin has 
only been shown by one method, namely equilibrium gel filtration (Horwitz et al., 1986), and 
the direct association between talin and integrin within cells has not been proven (Simon and 
Burridge, 1994). 
Early studies (Burridge and Mangeat, 1984) failed to detect any direct interaction 
between talin and actin. Based on in vitro binding assays of purified proteins, a potential 
multi-protein bridge connecting the membrane to actin filament bundles was proposed 
(Burridge et al., 1988). Because an interaction between vinculin and a-actinin, another 
actin-binding protein, had been reported (Wachsstock et al., 1987), actin filaments might be 
linked to the cytoplasmic face of the plasma membrane sequentially via integrin, talin, 
vinculin, and a-actinin (Burridge et al., 1988). Alternative connections between the 
cytoskeleton and plasma membrane almost certainly exist because an interaction between a-
actinin and integrin has also been identified (Otey et al., 1990), which would provide a more 
direct linkage between the cytoskeleton and plasma membrane via these two proteins 
(Burridge et al., 1990; Simon and Burridge, 1994). Recent studies have shown that vinculin 
has an actin-binding site on its 30 kDa domain whose activity is regulated by the 
intramolecular interaction between it and the 90 kDa N-terminal head domain (Johnson and 
Craig, 1995). Intact vinculin shows little if any actin binding activity (Evans et al., 1984), but 
the isolated 30 kDa fragment crosslinks and bundles actin filaments strongly (Johnson and 
Craig, 1995). The physiological significance of the intramolecular interaction of vinculin is 
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not yet clear, and the in vivo agents that may regulate the intramolecular interaction that 
controls vinculin's actin binding properties have not been identified. The identification of a 
vinculin-actin interaction in vitro provides an alternative linkage between the actin-based 
cytoskeleton and the plasma membrane. The interactions among the proteins at focal 
adhesions appear to be very complex as more and more proteins, as well as interactions 
between and among them, have been and presumably v^dll continue to be identified. 
Although direct binding between talin and actin was identified by Muguruma et al. 
(1990), there is little agreement on the nature of the interaction. This interaction supposedly 
involves the binding of talin to both monomeric actin (G-actin) and polymerized actin (F-
actin) as detected by cosedimentation, gel filtration, and chemical crosslinking (Muguruma et 
al., 1990, 1992). Muguruma et al. (1990) used talin purified from avian smooth muscle and 
showed that it binds to actin filaments and slightly increases the viscosity of F-actin 
solutions. However, no clear evidence of actin crosslinking activity was detected. Discovery 
of the direct talin-actin interaction generated yet another alternative direct linkage between 
actin filaments and the plasma membrane, i.e., talin might link actin to the transmembrane 
integrins (Simon et al., 1991). The actin binding site(s) in talin has been localized to the 190 
kDa fragment, the major fragment generated by calpain (Muguruma et al., 1990, 1995). 
However, the specific binding sequence site(s) has not been identified. Human platelet talin 
has been reported to increase the nucleation process of actin filament formation and to 
decrease the viscosity of F-actin solutions (Kaufhiann et al., 1991). The reported binding 
constant is 0.25 |iM, with a maximal binding molar ratio of 3 G-actins to 1 talin. Isenberg 
and Goldmann (1992) suggest this implicates talin as a key protein in mediating actin 
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filament assembly at the cell membrane. Schmidt et al. (1993) showed that talin bound to 
actin filaments and increases viscosity of the F-actin solutions. The interaction is much 
stronger at low pH and low ionic strength, and weakens as pH and/or ionic strength 
increases. Gelating of the F-actin solution by talin suggested the possibility that talin 
possessed actin crosslinking activity (Schmidt et al., 1993). 
The apparent conflicts in the results reported on talin fi-om different laboratories may be 
due to (1) the differing degree of protein homogeneity, (2) the different species and tissues 
used to prepare the talin, (3) the different types and/or degrees of post-translational 
modifications, and (4) the different ionic conditions employed in the experiments. Although a 
direct interaction between talin and actin has been shown, the regulation and exact nature of 
the interaction have yet to be clarified. A major objective of my Ph.D. research was to 
improve our understanding of the nature of the talin-actin interaction. 
Actin 
The actin molecule has been highly conserved during evolution by showing minimal 
differences in the actin sequences of different tissues and species. Multiple actin genes have 
been identified and found to be expressed in different tissues, but they all share a high degree 
of homology in sequence (Bamburg and Berstein, 1991). The structure of the actin molecule 
has been indirectly resolved by subjecting crystals formed fi'om 1; 1 complexes of actin with 
DNase I to X-ray diffraction analysis. The structure of the DNase I was then subtracted from 
the density map because it has been determined independently (Kabsch et al., 1990). The G-
actin molecule consists of a single polypeptide chain of 375 amino acids (molecular weight 
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of 42,000) with a pi of ~ 5.4, a tightly complexed nucleotide (ATP or ADP) and divalent 
cation, and has overall dimensions of -5.5 x 5.5 x 3.5 nm (Kabsch et al., 1990). The actin 
monomer is composed of a large and a small domain (actually they are nearly the same size), 
separated by a cleft in which the nucleotide (ATP or ADP) and an associated calcium ion are 
bound (Kabsch et al., 1990). There is one high affinity and several low afSnity cation binding 
sites in the actin molecule. The small domain contains both the N- and C-termini, and can be 
fiirther divided into subdomains 1 and 2, whereas the large domain can be further divided 
into subdomains 3 and 4. Subdomains 1 and 3 are structurally similar, suggesting that they 
may have arisen from gene duplication (Kabsch et al., 1990). 
Monomeric actin (G-actin) of molecular weight 42,000 assembles in the presence of 
MgClz or KCl to form linear polymers consisting of two staggered parallel rows twisted in a 
right-handed helix (F-actin), with a crossover occurring every 13 actin molecules or 36 nm 
along the actin filament (Kabsch et al., 1990). The actin monomer is arranged in the actin 
filament so that its large domain is located in the center of the filament, while its small 
domain is exposed (Kabsch et al., 1990). The actin polymerization reaction is reversible, and 
the extent of polymerization is determined by the temperature, ionic conditions, and the 
presence of actin binding proteins in the solution (for reviews see Stossel et al., 1985; 
Pollard and Cooper, 1986). Both hydrophobic and electrostatic forces are believed to 
contribute to the noncovalent bonds holding the subunits together within the polymer. As 
mentioned previously, actin monomers bind the adenine nucleotides ATP and ADP, and 
actin polymerization is associated with the hydrolysis of actin-bound ATP to ADP. Actin 
polymerization can be initiated by addition of monovalent and/or divalent cations (Stossel et 
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al., 1985; Pollard and Cooper, 1986). Actin filaments are polar structures, and have "barbed" 
(+) and "pointed" (-) ends, which are often determined by labelling the filaments with heavy 
meromyosin (Pollard, 1986). The concentration of free monomers required to maintain the 
steady state, known as the critical monomer concentration, is lower at the barbed end than at 
the pointed end. At approximately physiological conditions, these actin concentrations are 
0.1 nM and 1.5 nM, respectively. Therefore, actin monomers add more rapidly to the barbed 
end than to the pointed end of an actin filament (Stossel et al., 1985; Pollard and Cooper, 
1986). 
Actin polymerization (for reviews see Stossel et al., 1985; Pollard and Cooper, 1986) 
has at least three major steps: (1) the activation step, which is solely dependent on the salt 
concentration, and leads to a conformational change in the monomeric actin molecules; (2) 
the nucleation step, which is the formation of dimeric and trimeric actin nuclei and is 
generally the rate-limiting step of actin polymerization; and (3) the elongation step, which is 
the process of adding actin monomers to the nuclei and growing actin filaments. Elongation 
of actin filaments proceeds at a high rate as soon as stable nuclei have been created. 
Actin binding proteins can be classified into five groups according to their effects on 
different steps of actin polymerization and on F-actin organization (for reviews see Stossel et 
al., 1985; Pollard and Cooper, 1986; Hartwig and Kwiatkowski, 1991) as follows: (1) 
monomer sequestering proteins, including profilin, thymosin P-4, DNase I, vitamin D-
binding proteins, etc., which predominantly bind to actin monomers and prevent actin from 
polymerizing; (2) filament-severing proteins, including gelsolin, fragmin, villin, severin, etc., 
which sever actin filaments and also nucleate and cap actin filaments in a Ca^^-dependent 
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way; (3) filament end-blocking (capping) proteins, including CapZ, CapG, etc., nearly all of 
which bind to the barbed end of actin filaments and inhibit filament elongation in a calcium 
independent way. For many of these proteins, a nucleating activity also has been reported, 
but they normally do not have severing activities; (4) F-actin side-binding proteins, including 
tropomyosin, caldesmon, etc., which bind laterally to the sides of actin filaments; and (5) F-
actin crosslinking proteins, including a-actinin, filamin, spectrin, fimbrin, ABP-SO, etc., 
which bind to actin filaments and crosslink actin filaments into networks and/or bundles. 
About 20 kinds of different actin binding domains have been identified, which don't display 
sequence homology with each other or with other non-actin binding proteins. Quite often, 
however, there is a sequence homology, or secondary structure similarities, among the 
proteins within the same group (e.g., the spectrin super family) (Hartwig and Kwiatkowski, 
1991). One actin-binding protein may have multi-actin binding activities due to multiple actin 
binding domains. The activities of a number of actin binding proteins have been shown to be 
regulated by phosphoinositides (Isenberg, 1991; Janmey, 1994). 
Actin-binding proteins and phosphoinositides 
Inositol-containing phospholipids are ubiquitous components of eukaryotic cells (for 
reviews see Berridge, 1987; Majerus, 1992). They constitute 2-8% of total phospholipids. 
Compared to all the other phospholipids in the membrane, phosphatidylinositol (PI) is unique 
in that it can be further phosphorylated. A PI kinase transfers a phosphate from ATP onto 
the 4-position of the inositol head group to give phosphatidylinositol 4-phosphate (PIP). A 
separate PIP kinase adds another phosphate to the 5-position to give phosphatidylinositol 
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4,S-bisphosphate (P1P2)- Among the three phosphoinositides, PI accounts for more than 
80% of the total. 
Increased hydrolysis of PIPj to diacylglycerol (DAG) and inositol 1,4,5-trisphosphate 
(IP3) has been observed in many different cell types in response to a variety of external 
stimuli including neurotransmitters, hormones, growth factors, etc., and has led to the 
proposition of a bifiircating signal transduction pathway (Berridge, 1987; Berridge and 
Irvine, 1989). The stimulation of cell surface receptors initiates hydrolysis of the membrane-
bound PIP2 by phosphoinositide specific phospholipase C (PLC), and provides at least two 
second messengers, DAG, which remains in the membrane, and IP3, which is released into 
the cytosol (for reviews see Berridge, 1987; Berridge and Irvine, 1989). The DAG 
stimulates protein kinase C activity, whereas IP3 binds to its receptor in the endoplasmic 
reticulum and mobilizes calcium. These signal transduction pathways are now known to 
regulate a large array of cellular processes, including metabolism, secretion, contraction, 
neural activity and cell proliferation (Berridge and Irvine, 1984, 1989; Berridge, 1987; 
Majerus, 1992). The PIPj is then regenerated through a series of phosphorylation steps, and 
thus completes the so-called PI (phosphoinositol) cycle. However, only a small proportion 
(10-20%) of the entire phosphoinositide pool is involved in signalling, and only ~ 60% of 
total PIP2 in the plasma membrane is hormone-sensitive and available for signalling 
(Berridge, 1987). Recently, a non-signalling role for the phosphoinositides in vesicular traffic 
in yeast and mammalian cells has been described (Burgoyne, 1994). A phosphoinositide 
transfer protein (PITP) was found to transfer phosphoinositides and, to a lesser extent, 
phosphatidylcholine (PC), between lipid bilayers. The PITP may be involved in exocytosis 
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and in the maintenance of the PI levels required to provide the substrate PIPj for 
phospholipase C (Burgoyne, 1994). The presence of phosphoinositides in the lipid bilayer of 
organelles might be important in allowing fusion of transport vesicles with their target 
membranes, such as by inserting newly synthesized PI into membranes and/or in enabling 
binding of cytosolic and/or cytoskeletal proteins to transport vesicles (Burgoyne, 1994), 
especially since a number of cytoskeletal proteins have been shown to interact with 
phosphoinositides (for reviews see Isenberg, 1991; Janmey, 1994). 
The following part of my review will emphasize the interaction between phospholipids, 
especially the phosphoinositides, and actin-binding proteins, and the effects of 
phosphoinositides on the activities of these actin-binding proteins. 
Actin itself has been shown to interact with lipids. At a given surface pressure, increasing 
the density of positive charges in synthetic lipid monolayers causes a significant increase in 
the intercalation of the actin within the lipid molecules, thereby indicating that the adsorption 
of actin is facilitated by electrostatic interactions (Grimard et al., 1993). 
Actin monomer sequestering proteins - Profilins are small (molecular mass of 12-15 
kDa dependent on the source), soluble, basic proteins that are present in fairly high 
concentrations (30-40 jiM) throughout the cytoplasm. Profilin inhibits actin polymerization 
by binding to actin monomer at its C-terminus to form a 1; 1 complex (profilactin) (Lassing 
and Lindberg, 1985; Katakami et al., 1992; McLaughlin, 1995), and to a lesser extent to 
actin filament ends (Stossel et al., 1985; Pollard and Cooper, 1986), 
The binding between profilin and actin is regulated by anionic phospholipids (Lassing 
and Lindberg, 1985; 1988a). Anionic phospholipids, at low ionic strength and relatively high 
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calcium concentration, interact with isolated profilin and with profiiactin causing the 
dissociation of profiiactin, and in turn permitting the released actin to polymerize. Among 
the anionic phospholipids, PIP2 was found to be the most effective, followed by PIP, PI, 
phosphatidic acid (PA), and phosphatidylserine (PS), whereas cationic phospholipids 
(phosphatidylcholine and phosphatidylethanolamine), DAG, and IP3 were inactive (Lassing 
and Lindberg, 1985; 1988a). As ionic strength was increased to near-physiological levels of 
KCl and Ca^^, the phosphoinositides were the only phospholipids that remained highly active 
in binding to profilin and in dissociating the profiiactin complex (Lassing and Lindberg, 
1988a). On the other hand, a decrease in the concentration of calcium increases 
phosphoinositides' activity (Lassing and Lindberg, 1988a). The binding stoichiometry is 
about 10 molecules of PIP2 needed to dissociate one molecule of profiiactin. The PIPj acts 
on profilin or profiiactin by binding to profilin, presumably by electrostatic forces between 
the negatively charged polar head groups of the micelle and the basic side chains on profilin. 
The increase seen in activity of the phosphoinositides with increasing phosphorylation state 
of the inositol ring demonstrates the importance of the phosphate groups in the 
inositide/profilin interaction. The relatively strong interference with this interaction caused 
by addition of Ca^"^ also demonstrates the importance of the phosphate groups, because 
chelation of divalent cations by these phospholipids most likely involves the phosphate 
groups on the inositol ring. However, IP3 by itself does not cause dissociation of profiiactin 
(Lassing and Lindberg, 1988a). The latter result indicates that the interaction may involve 
both the inositol ring and the acyl chains. 
Profilin, in turn, also regulates the PI cycle by binding to PEP^, and competes efficiently 
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with platelet cytosolic phosphoinositide-specific phospholipase C (PLC) for interaction with 
its substrate, PIPj (Goldschmidt-Clermont et al., 1990). Each profilin obstructs the access of 
PLC to ~ 10 molecules of PIPj. However, only the activity of the unphosphorylated PLC-y 
isoform on PIP2 hydrolysis is inhibited by binding of profilin. The phosphorylation of PLC-Y 
by the epidermal growth factor (EGF) or platelet derived growth factor (PDGF) receptors, 
upon stimulation of the cell, overcomes the inhibition. Profilin does not inhibit the action of 
another PLC isoform, PLC-P, on PIP2 hydrolysis (Goldschmidt-Clermont et al., 1991). 
The high concentration of profilin in cells and its ability to bind actin monomers, which is 
regulated by phospholipids, have led to the suggestion that profilin together with 
phosphoinositides may help buffer the actin monomer concentration in cells. This role is now 
attributed in part to profilin and mainly to thymosin P-4 (Safer and Nachmias, 1994), and 
suggests a close relationship between the PI cycle and microfilament based cell motility 
(Lassing and Lindberg, 1988b). 
The pancreatic secretory protein DNase-I (31 kDa), is another actin monomer 
sequestering protein, whose enzyme activity can be inhibited by the binding of PIP2 
(Yonezawa et al., 1990). DNase-I binds to actin at its N-terminus, which is diflFerent from 
most actin-binding proteins, and depolymerizes actin filaments and binds to the barbed end 
of actin filaments. Its actin-depolymerizing activity is also inhibited by Pff 2 and PIP, but not 
by PI, PS, PC, IP3, and DAG (Yonezawa et al., 1990). 
Actin filament-severing proteins - Gelsolin (87 kDa) is a multifunctional actin-binding 
protein, which (1) binds to actin monomers and stimulates the formation of actin nuclei; (2) 
acts as a capping protein at the barbed end of actin filaments, which takes place to a small 
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extent in the presence of submicromolar Ca^^ but to a greater extent at higher Ca^"^ 
concentration; and (3) severs actin filaments in a Ca^^ dependent manner, which does not 
occur at submicromolar Ca^^ concentration (for reviews see Stossel et al., 1985; 
McLaughlin, 1995). One gelsolin can complex with two actin monomers, which in turn 
serves as a nucleus for actin polymerization. Removing Ca^^ with EGTA only dissociates one 
of the two actin monomers. The resultant EGTA-resistant gelsolin-actin complex cannot 
sever actin filaments. Micelles of PIP2 dissociate EGTA-resistant gelsolin-actin complexes, 
and restore gelsolin's capacity to sever actin filaments in vitro (Janmey et al., 1987). The 
severing function of gelsolin can be almost completely eliminated by low concentrations of 
PIP2, even in the presence of 200-1000 |iM Ca^^. The half maximal inhibition of its severing 
function requires 20 moles of PIP2 for 1 mole of gelsolin. In contrast to the effect on 
severing, the ability of gelsolin to nucleate filament assembly is much less inhibited by an 
equivalent amount of PDPj (Janmey and Stossel 1987). Gelsolin has at least three actin 
binding domains (Bryan, 1990), and its actin modulating activities are due to one or a 
combination of the domains. The site affected by PIPj seems to be in the N-terminal half of 
gelsolin, and two potential PIP2 binding sites on gelsolin have been located at residues 130-
149 (Yu et al., 1992) and residues 150-169, which both contain numerous basic amino acid 
residues (Janmey et al., 1992). Residues 150-169 may also be its actin binding site (Bryan, 
1990). The effect of the lipid is highly specific, as there is no inhibition by PI, PA, DAG, IP3, 
glycerophosphatidylinositol 4,5-bisphosphate, or PS. Treatment ofPIPj with phospholipase 
A2 or C, or with an excess of the non-ionic detergents Triton X-100 or Tween-20 before 
addition to gelsolin eliminates its inhibitory effect, which suggests that micelle structure is 
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important for PIPz's function. A similar inhibitory effect occurs only when PIP is extensively 
sonicated, indicating that the effects of PIP2 or PIP on gelsolin depend on the physical state 
of the phosphoinositides and, thus, can be affected by a variety of chemical agents. Any 
molecule that decreases the exposure of the hydrophilic head groups of the 
phosphoinositides to the solvent decreases inhibition of gelsolin by the phosphoinositides 
(Janmey et al., 1987). This can be achieved by trapping phosphoinositides in the interior of 
multilaminar vesicles composed of other lipids, by formation of aggregates containing PIP2 
by divalent cations, or by masking of the head groups following binding to profilin (Janmey 
et al., 1987). Alternatively, an agent that mixes with phosphoinositides at sufficiently high 
concentrations may also decrease the effect of phosphoinositides on gelsolin, apparently by a 
dilution effect (Janmey and Stossel, 1989). However, the charged groups on the 
phosphoinositide head groups do not appear to play a direct role in gelsolin regulation 
because both PIP and PIPj inhibit gelsolin's actin binding activities in the presence of 
millimolar Mg^^ concentrations, and the effects of PEPj are constant over a range of pH 
within which phosphate groups become protonated (Janmey and Stossel, 1989). 
Like profilin, gelsolin also competes with phospholipase C for interaction with PIP2 and, 
thus, inhibits PIP2 hydrolysis by PLC in platelets. The 1; 1 gelsolin/actin complex does not 
have the inhibitory effect on PIP2 hydrolysis (Banno et al., 1992). 
Cofilin (21 kDa) is a widely distributed actin modulating protein that has the ability to 
bind along the side of F-actin and to depolymerize F-actin in a pH dependent manner 
(Yonezawa et al., 1990). It depolymerizes F-actin partially at approximately neutral pH and 
completely at more alkaline pH (>7.3). This pH-dependent change in its depolymerizing 
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activity is reversible (Yonezawa et al., 1990). It has a sequence homology to that of gelsolin, 
villin, fragmin, severin, and Acanthamoeba profilin in its C-terminal portion (Yonezawa et 
al., 1990). Under physiological conditions, it can bind both G-actin and F-actin in a 1; 1 
molar ratio. PI, PIP, and PIPj have an inhibitory effect on its actin binding activities, whereas 
PC, PS,, and IP3 have little or no effect (Yonezawa et al., 1990). Gel filtration analyses 
showed that PIP^ bound to cofilin and thereby inhibited the binding of cofilin to G-actin 
(Yonezawa et al., 1990). The binding site for both actin and PIP2 is located on residues 104-
115 in cofilin, which indicates that PIP2 may inhibit the interaction between cofilin and actin 
by competing with the binding of actin (Yonezawa et al., 1991). The binding of cofilin to 
PIP2 inhibits PIP2 hydrolysis by PLC-y (Yonezawa et al., 1990). Destrin (19 kDa) is a pH 
independent actin depolymerizing protein. Destrin's actin binding activity is also inhibited by 
PI, PIP, PIP2, but not by PC, PS, and IP3, and it is very similar in sequence to cofilin 
(Yonezawa et al., 1990). 
Actin filament end-blocking (capping) proteins - CapZ is an a/p heterodimer that can 
bind to the barbed end of actin filaments and nucleate actin polymerization. It does not 
require Ca^"^ for these activities (Pollard and Cooper, 1986). Anionic phospholipids, such as 
PIP2, completely inhibit the ability of CapZ to affect actin polymerization (Heiss and Cooper, 
1991). The nucleation and capping activities of CapZ are both inhibited. PIP2 inhibits the 
binding of actin to CapZ by binding to CapZ at a molar ratio of ~ 400 PIPj to 1 CapZ (Heiss 
and Cooper, 1991). All of the anionic phospholipids, including PIP2, PIP, PI, PS, PG, and 
PA, inhibited CapZ in the order of PEPj = PIP > others, but the neutral phospholipids PC and 
PE do not inhibit CapZ (Heiss and Cooper, 1991). 
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Actin filament side-binding and crosslinking proteins - A recent study has shown that 
a-actinin from striated muscle is an endogenous PIPj-bound protein, containing a molar 
ratio of 20-30 moles of PIP2 to one mole of a-actinin (Fukami et al., 1992). The specific 
interaction between PIP2 and a-actinin regulates the F-actin-gelating activity of a-actinin 
(Fukami et al., 1992). Exogenously added PIP2 can enhance the actin gelating activity of 
smooth muscle a-actinin to the level seen for striated muscle a-actinin. However, a large 
amount of exogenous PIPj inhibited the gelating activity of a-actinin on F-actin solutions 
(Fukami et al., 1992). The presence of 0.5% Triton X-100, even at the high concentration of 
PIP2, permitted the gelating activity of striated muscle a-actinin, suggesting that large PIP2 
micelles induce aggregation of a-actinin-PIPi complexes and prevent actin crosslinking 
(Fukami et al., 1992). 
Both a-actinin and meta-vinculin have been shown to bind to phospholipid liposomes 
(Niggli and Gimona, 1993). Incubation of a-actinin with vinculin or metavinculin strongly 
inhibited the binding of a-actinin to phospholipid (Niggli and Gimona, 1993). These results 
suggest the formation of a ternary complex of vinculin, a-actinin and phospholipid (Niggli 
and Gimona, 1993). Vinculin and a-actinin were further shown to be present in PIP2-bound 
forms, and involved in signalling by tyrosine phosphorylation (Fukami et al., 1994). 
Micelles of inositol phospholipids have been shown to bind to smooth muscle filamin and 
inhibit its ability to form a gel of F-actin (Furuhashi et al., 1992). The effectiveness of the 
phospholipids is in the order of PIP2> PIP > PI. At a modest concentration of PIPj, activity 
of filamin is totally inhibited (Furuhashi et a!., 1992). 
The earliest studies on the interaction between talin and membrane components showed 
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that talin purified from detergent-lysed human platelets was reconstituted into neutral 
phospholipid PC bilayers with a low incorporation rate (Heise, et al., 1991). This interaction 
was greatly enhanced in the presence of negatively charged lipids. Platelet talin purified from 
detergent-lysed membrane fraction interacted electrostatically and hydrophobically with lipid 
membranes. The talin isolated from the cytoplasmic pool, however, failed to interact 
hydrophobically with lipid bilayers, and exhibited only electrostatic interactions with model 
membranes (Heise et al., 1991). A fi^eeze-thaw technique was used to show a uniform 
orientation of platelet talin, with its large head group pointing to the exterior of the vesicles 
(right-side-out orientation) (Heise, et al., 1991). A film balance technique was used to show 
that fluoresently labelled talin, as well as native talin, interacts with negatively charged lipid 
monolayers (Dietrich et al., 1993). Further study showed that talin selectively reacts with the 
hydrophobic part of negatively charged liposome bilayers (Goldmann et al., 1992). 
Thrombin proteolytic fragments of talin were purified, and their interactions with 
liposomes were studied (Niggli et al., 1994). The ~ 200 kDa fragment was shown to 
nucleate actin filament formation and reduce the viscosity of filamentous actin, which is 
comparable to these activities of intact talin. The 47 kDa fragment, however, did not have 
this activity. The 47 kDa fragment, but not the 200 kDa fragment, interacted specifically 
with large liposomes containing acidic phospholipids (Niggli et al., 1994). Similar results 
with acidic phospholipids have been shown with smooth muscle talin (Muguruma et al., 
1995). These results indicate that the membrane binding ability of talin is in its N-terminal 47 
kDa fragment. 
One of the objectives of my dissertation research was to investigate the effect of 
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phospholipids, especially the phosphoinositides, on the talin-actin interaction. 
The physiological significance of the interaction between phosphoinositides and actin-
binding proteins remains to be resolved. In skeletal muscle, PIP and PI are found in 
transverse tubules and terminal cistemae of the sarcoplasmic reticulum, whereas PIP2 
found in the transverse tubules but not in terminal cistemae (Milting et al., 1994). In 
addition, a much greater pool of PIP2 is located in the sarcolemma some distance away firom 
the triadic junctions (Milting et al., 1994). By immunofluorescent staining, PIP2 was found to 
be present in high density in the central areas around nuclei, microfilament bundles, and focal 
contacts (Fukami et al., 1994). The concentration of PIPj in cells such as platelets is around 
300 nM when averaged over the entire cell volume (Rittenhouse and Sasson, 1985), which 
is about the same concentration of unpolymerized actin in platelets (Goldschmidt-Clermont 
et al., 1990). Therefore, the signal transduction pathway involving phosphoinositides may be 
directly linked to the cytoskeleton by regulating the activities of actin-binding proteins and, 
as a result, the organization/reorganization of the cytoskeleton and cell motility. 
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TALIN CAN CROSSLINK ACTIN FILAMENTS INTO BOTH NETWORKS AND 
BUNDLES 
A paper submitted to Biochemical and Biophysical Research Communications 
Jinwen Zhang, Richard M. Robson, Jean M. Schmidt, and Marvin H. Stromer 
Summary 
The talin-actin interaction was examined by using negative staining and cosedimentation 
assays. At pH 6.4 and low ionic strength, talin extensively crosslinked actin filaments into 
both networks and bundles. The bundles consist of parallel actin filaments with a center-to-
center distance of 13 nm, and talin crossbridges spaced at 36 nm intervals along the bundles. 
As pH was increased stepwise from 6.4 to 7.3, talin's bundling activity was decreased first, 
then its networking activity. Qualitatively similar results were obtained at pH 6.4 by 
increasing ionic strength. Chemical crosslinking indicated talin was present as a dimer from 
pH 6.4 to 7.3, with or without added KCl. The results show that talin can interact directly 
with actin filaments by formation of actin filament networks and bundles, with the bundles 
more sensitive to dissolution by increase in pH or ionic strength. 
Introduction 
Talin is a component of cell-matrix type adherens junctions where actin filaments are 
linked in some manner to the cell membrane (1,2). Talin has been shown to bind in vitro to 
vinculin (3-6), the integral membrane protein integrin (7), dystrophin (8), and focal adhesion 
kinase (9). Early reports, however, found no direct talin-actin interaction (1,4,10). Thus, 
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talin initially was proposed to be one component in a multi-protein bridge linking actin 
filaments to the cytoplasmic face of the cell membrane (1). Subsequently, direct interaction 
in vitro between talin and actin was shown (11,12), indicating that talin also might directly 
link actin filaments to integrin of the cell membrane (13). The reported nature of the talin-
actin interaction fi'om different labs varies considerably, however, with talin shown to 
increase (11,14,15) or to decrease (12,16) viscosity of F-actin solutions. We have 
demonstrated that the direct talin-actin interaction is very sensitive to ionic conditions such 
as pH (15) that may explain, in part, variability in reports on talin from different labs. The 
purpose of this study is to provide a structural basis for the effects of ionic conditions on the 
talin-actin interaction. We show for the first time that talin can crosslink F-actin into both 
networks and bundles, and that formation of these macromolecular assemblies is reduced 
with increasing pH or ionic strength. 
Materials and Methods 
Actin and talin preparation - Porcine skeletal muscle actin and highly homogeneous 
turkey (gizzard) smooth muscle talin were prepared as described (15). Purity of both 
proteins is shown in Fig. 1. The modified Lowry method (Sigma) was used to determine 
protein concentrations. 
Electron microscopy - Talin (0.10 mg/ml final concentration) and G-actin (0.25 mg/ml 
final concentration) were mixed in buffer A (10 mM imidazole-HCl, 1 mM ATP, 1 mM 
'EGTA) at selected pH values, with pH adjustment of all buffers done at 25°C. Actin 
polymerization was induced by either MgClj (2 mM final concentration) or MgClj plus KCl 
Fig. 1. SDS-PAGE of purified talin and actin. Lane 1, talin (5 ^ig); lane 2, actin (5 ^g). T 
= talin, A = actin. 
1 2 
A • 
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(2 mM and 200 mM final concentrations, respectively). After addition of MgClz or of MgClj 
plus KCl, final pH values tested were 6.4, 6.9, or 7.3. After incubation for 1 hr at 25° C, a 
drop of the actin control or actin-talin mixture was applied to a 400-mesh carbon-coated 
copper grid, negatively stained with 2% aqueous uranyl acetate, and observed with a JEOL-
100 CX n electron microscope operated at 80 kV. Representative areas were photographed. 
The distance between actin filaments in actin bundles and the spacing between crossbridges 
along actin bundles were determined fi-om five different preparations of talin and actin. The 
average distance and spacing were each determined fi'om more than 100 measurements 
(data reported as means ± S.D.) of randomly selected images. 
Cosedimentation assay - Talin (0.20 mg/ml final concentration) and G-actin (0.50 
mg/ml final concentration) were mixed in buffer A at 25° C. Actin polymerization was 
initiated by adding MgClj (2 mM final concentration) or MgClj plus KCl (2 mM and 200 
mM final concentrations, respectively). The final pH was 6.4. The solution was mixed, 
incubated at 25° C for 1 hr, and centrifiiged at 110,000 x g in a Beckman airflige for 20 min. 
Comparable amounts of pellets and supematants were analyzed by 10% SDS-PAGE (17). 
Chemical Crosslinking - Talin (0.20 mg/ml) in buffer A containing 2 mM MgClj at pH 
6.9 and vinculin (0.20 mg/ml) in 10 mM imidazole-HCl, pH 6.9, were each crosslinked with 
EDC (20 mM final concentration). Aliquots were taken at specific time points and the 
reaction was quenched with 20 mM glycine, 20 mM Tris-HCl, pH 8.0. The samples were 
*The abbreviations used: EGTA, ethylene glycol bis (P-amino-ethyl ether) N,N,N',N', 
tetraacetic acid; EDC, l-ethyl-3-(3-dimethylaminopropyl) carbodiimide; EFla, elongation 
factor la; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis. 
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analyzed by SDS-PAGE. The vinculin, which served as a control, was obtained from a peak 
eluted during the DEAE-cellulose chromatography step used in the talin preparation, and 
then purified by sequential chromatography on hydroxyapatite (BioRad) and Sephacryl S-
300 HR (Pharmacia) columns. 
Results 
We previously demonstrated a marked pH dependence in the talin-actin interaction, with 
talin's abilities to cosediment with actin filaments and to increase the low shear viscosity of 
F-actin solutions significantly increased as pH was lowered (15). The effect of pH on the 
talin-actin interaction as examined by negative staining is shown in Fig. 2. The actin filament 
controls formed in the absence of talin at pH 6.4 and 6.9 (Fig. 2A and 2C, respectively) are 
similar in appearance, with the filaments randomly dispersed. However, as shown in Fig, 2B, 
talin (at a molar ratio of ~ one 225 kDa talin to thirteen 42 kDa actin monomers) extensively 
crosslinked actin filaments at pH 6.4 into both networks and bundles. The networks (NW) 
consist of actin filaments brought into a close or tight meshwork. The bundles varied in 
appearance. Some appeared as thin sheet-like bundles (TSB), in which several actin 
filaments were aligned equidistant from each other, with periodic crosslinks (talin particles) 
giving them a distinct, ordered two-dimensional appearance. Others appeared as tight 
bundles (TB), in which the adjacent actin filaments were roughly parallel, but not equidistant 
from each other (Fig. 2B). As shown in Fig 2D, talin still had the ability to crosslink actin 
filaments at pH 6.9 into networks (NW) and bundles, but the activity was considerably 
decreased. At pH 6.9 thin sheet-like bundles were absent and the actin bundles often had 
Fig. 2. The pH dependence of the talin-actin interaction as shown by electron 
microscopy. Actin (0.25 mg/ml) in the absence or presence of talin (0.10 mg/mi) was 
polymerized in buffer A by the addition of MgClj (2 mM final concentration). (A) Actin 
control polymerized in the absence of talin at pH 6,4; (B) actin polymerized in the presence 
of talin at pH 6.4. NW = network, TSB = thin sheet-like bundle, TB = tight bundle; (C) actin 
control polymerized in the absence of talin at pH 6.9; (D) actin polymerized in the presence 
of talin at pH 6.9. Globular particles often were observed at points of filament intersection in 
networks (NW). TRA = talin rich actin filaments, BA = bare actin filaments. Bar = 100 nm 
for A-D. 
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alternating regions of talin-rich actin filaments (TRA) and bare actin filaments (BA) (Fig. 
2D). At pH 7.3, talin's actin filament crosslinking activity was further reduced, with no 
evidence of actin bundles, and only slight evidence of actin networks (results not shown). 
Examples of three actin bundle structures typically observed in the presence of talin at 
pH 6.4 and low ionic strength are shown at higher magnification in Fig. 3. The thin sheet-
like bundle shown in Fig. 3 A consists of four parallel actin filaments, with a consistent 
longitudinal periodicity of crossbridges along the bundle (shown by brackets). Each 
crossbridge, as defined herein, consists of two closely spaced talin particles (shown as pairs 
of arrows) perpendicular to the long axis of the bundle. The average center to center 
distance between adjacent actin filaments in the thin sheet-like bundles, and the spacing of 
crossbridges along the longitudinal axis of the actin bundles, were 12.9 ± 0.6 nm and 36.2 ± 
1.7 nm, respectively. Other actin bundles were observed that exhibited a similar longitudinal 
periodicity (-36 nm) of talin crossbridges (Fig. 3B), but they were not as highly ordered in 
appearance as the bundle shown in Fig. 3 A, and some actin bundles crosslinked by talin 
present at pH 6.4 exhibited no obvious longitudinal periodicity (Fig. 3C). We observed 
throughout our study that actin bundles exhibiting the ~ 36 nm longitudinal periodicity (e.g., 
Fig, 3 A and 3B) were only observed at low pH (~ 6.4) and low ionic strength. 
The effect of ionic strength on the interaction of talin and actin at pH 6.4 was examined 
by negative staining and cosedimentation (Fig. 4). Actin filaments, in the absence of talin, 
formed in the presence of 2 mM MgClj and 200 mM KCl at pH 6.4 (Fig. 4A) were randomly 
dispersed and similar to the actin filament controls formed in the presence of 2 mM MgClj at 
pH 6.4 (Fig. 2A). However, in the presence of the 200 mM KCl, talin lost its ability to 
Fig. 3. Examples of talin's ability to bundle actin filaments at pH 6.4 as shown by 
electron microscopy. Actin (0.25 mg/ml) in the presence of talin (0.10 mg/ml) was 
polymerized in buffer A by the addition of MgCli (2 mM final concentration) at pH 6.4. (A) 
Some actin filaments were crosslinked by talin (shown by arrows) into thin sheet-like 
bundles with a longitudinal periodicity (shown by brackets); (B) some actin filaments were 
crosslinked by talin (shown by arrows) into small bundles with a longitudinal periodicity 
(shown by bracket); (C) some actin filaments were crosslinked by talin (shown by arrows) 
into tight bundles with a less distinct longitudinal periodicity. Bar = 100 nm for A-C. 

Fig. 4. The efTect of ionic strength on the talin-actin interaction as shown by electron 
microscopy and cosedimentation. (A and B) Electron microscopy. (A) Micrograph of 
actin (0.25 mg/ml) polymerized in the absence (A) or presence (B) of talin (0.10 mg/ml) by 
the addition of MgCla and KCl (2 mM and 200 mM final concentrations, respectively). 
Arrows in B indicate talin particles observed at points of filament intersection in networks. 
Bar = 100 nm for A and B. 
(C) Cosedimentation assay, (a) Talin control in buffer A containing 2 mM MgClj; (b) 
talin/actin mixture polymerized in buffer A containing 2 mM MgClj; (c) actin control 
polymerized in buffer A containing 2 mM MgClz; (d) talin control in buffer A containing 2 
mM MgClj and 200 mM KCl; (e) talin/actin mixture polymerized in buffer A containing 2 
mM MgClz and 200 mM KCl; (f) actin control polymerized in buffer A containing 2 mM 
MgCli and 200 mM KCl. s = supernatant, p = pellet, T = talin, A = actin. 
noKCl 200mMKCl 
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crosslink actin filaments at pH 6.4 into bundles (cf, Fig. 4B with Fig. 2B and Fig. 3), and its 
ability to crosslink actin filaments into networks also was significantly reduced (cf., Fig. 4B 
with Fig. 2B). The results obtained by cosedimentation assays on the effect of ionic strength 
on the talin-actin interaction at pH 6.4 (Fig. 4C) were in concert with the microscopy results. 
At low ionic strength (only 2 mM MgClj used in actin polymerization), about 90% of the 
talin cosedimented with the F-actin pellet (Fig 4C, panel b). In contrast, in the presence of 2 
mM MgClz and 200 mM KCl, approximately 15% of the talin cosedimented with the F-actin 
pellet (Fig. 4C, panel e), which is still more talin than was sedlmented in the pellet of the 
talin control (panel d) under the same ionic conditions. 
Recent crosslinking studies have indicated that talin probably functions as a dimeric 
molecule (two 225 kDa subunits) or possibly a higher oligomer (14,16,18). Our crosslinking 
results obtained with the zero-length crosslinker EDC at pH 6.9 and low ionic strength also 
showed that talin was present primarily as a dimer (Fig. 5A). With increasing crosslinking 
time, the amount of monomer band decreased concomitantly with an increase in amount of a 
band corresponding to an ~ 400 kDa protein (Fig. 5A). Vinculin, another adhesion plaque 
protein (19), remained as a monomer (Fig. 5B), as did G-actin when crosslinked in 
nonpolymerizing solutions (results not shown). We also observed crosslinking results on 
talin, similar to those shown in Fig. 5A, when the crosslinking was done at pH 6.9 in the 
presence of 100 mM KCl, as well as at pH 6.4 or 7.3, with or without 100 mM KCl (results 
not shown). Thus, talin was present primarily as a dimer from pH 6.4 to 7.3 at low and 
higher ionic strength. Overall, our crosslinking results on talin were in agreement with those 
of others (14,16,18). 
Fig. S. Chemical crosslinking of talin with EDC. Aliquots of the talin (A) and of the 
vinculin control (B) reaction mixtures were taken at specific time points, quenched, and 
analyzed by SDS-PAGE. Lane 1, proteins before addition of EDC; lanes 2, 3, 4, 5, 6, and 7, 
are after addition of EDC and represent 0, 10, 30, 60, 120, and 240 min of crosslinking, 
respectively. Numbers on the left of A correspond to the molecular mass (kDa) of protein 
standards, d = talin dimer corresponding to an ~ 400 kDa protein. 
A B 
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Discussion 
We show for the first time that when actin is polymerized into filaments at pH 6.4 and 
low ionic strength in the presence of talin, both actin networks and bundles are formed. 
Talin's actin filament crosslinking activity decreases with increase in pH and/or ionic 
strength, with its bundling activity lost first. These results provide a structural explanation 
for the marked pH dependence of the direct talin-actin interaction observed by low shear 
viscosity and cosedimentation assays (15). The sensitivity of the talin-actin interaction to 
ionic conditions may explain some of the reported differences in talin's effect on actin among 
some labs that have used different ionic strength and/or higher pH (~ 7.5-8.0) (4,11,14,15). 
It does not, however, seemingly account for reports of a talin-induced decrease in viscosity 
of actin solutions (12,16), in which it was suggested the decrease in actin viscosity, 
especially at short polymerization times, was due to an increase in number of actin filaments 
but decrease in filament length. We observed, however, in samples of talin-actin mixtures 
negatively stained after only five minutes of polymerization, that talin had crosslinked actin 
filaments into networks and bundles and, in comparison to control F-actin, there was no 
evidence of shorter filaments (results not shown). An alternative possibility for talin's actin 
viscosity reducing activity may be the purity of the talin used, which is especially critical at 
the rather high molar ratio of talin to actin used (- one talin to two actins) (12,16). Others 
have reported (13,20), that an actin severing contaminant(s) can be removed from platelet 
talin prepared by procedures similar to those described (12,16). 
The talin crossbridge spacing of ~ 36 nm observed in the well-ordered lattice of the thin 
sheet-like bundles (Fig. 2B; Fig. 3A and 3B) matches the - 36 nm actin filament crossover 
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periodicity (21) and approximates the longitudinal crossbridge spacing in actin bundles 
formed by some other actin crosslinking proteins, such as EFla (ABP-50) [33 nm (22)] and 
muscle a-actinin [36 nm (23)]. The filament to filament distance of ~ 13 nm is slightly 
larger than that in actin bundles formed by EFla [5 or 8 nm (22)] and fimbrin [9 nm (24)], 
similar to that of villin [12-13 nm (24)] and much less than muscle a-actinin [36 nm (23)]. 
The exact arrangement of the talin molecule(s) within the crossbridges will require more 
detailed analysis. This, too, is complicated because the reported size and shape of talin varies 
considerably (15,16,25-27), and is evidently dependent upon factors such as protein 
concentration and ionic strength. 
For an actin binding protein to crosslink actin filaments, it is expected to have two or 
more actin binding domains or one actin binding domain and the ability to self-associate 
(28). Although the -190 kDa tail domain generated by calpain cleavage contains talin's 
actin-binding activity (11,18), the actin binding domain(s) on talin has not yet been 
determined. Several reports suggest that native talin can (27) or does (14,16,18,25,26) exist 
as dimers and, thus, talin can be expected to have two (or more) actin binding sites. We have 
shown talin exists primarily as a dimer from pH 6.4 to 7.3, in the absence or presence of 
KCl. Thus, the effect of pH and ionic strength on talin's actin crosslinking activity observed 
herein appears due to an effect on the talin-actin interaction rather than on the ability of talin 
to self-associate. Several other proteins also have pH-dependent actin binding activities, such 
as ADF (29), gelsolin (30), x peptide (31), hisactophilin (32), and EFla (33). Interestingly, 
Edmonds et al. (33) reported that increasing pH in the physiological range of 6.6 to 7.0, or 
increasing the ionic strength, significantly decreased EFl a-mediated F-actin bundling 
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activity, a result analogous to what we observed with talin. Several studies (33-35) have 
shown that intracellular pH is altered in response to different cell signals. It is plausible the 
marked sensitivity to ionic conditions of the talin-actin interaction is important in 
cytoskeletal alterations occurring near the cell membrane in vivo. 
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EXAMINATION OF SELECTED FACTORS AND THEIR EFFECTS ON THE 
TALIN-ACTIN INTERACTION 
Summary 
Electron microscopy of negatively stained preparations was used to examine the effects 
of selected factors on talin's ability to interact with actin filaments. The results showed that 
increasing pH from 6.4 to 7.3 progressively decreased talin's ability to crosslink actin 
filaments into bundles and networks, and eventually eliminated talin's bundling activity. 
Increasing ionic strength at pH 6.4 by adding as little as 25 mM KCI considerably decreased 
talin's ability to crosslink actin filaments. Chemical crosslinking of talin wdth l-ethyl-3-(3-
dimethylaminopropyl) carbodiimide-HCI showed that talin was present primarily as a dimer 
of two ~ 225 kDa polypeptides from pH 6.4 to 7.3, at both low and higher ionic strength, 
indicating that talin functions as a dimeric molecule when it crosslinks actin filaments. Thus, 
the effect of pH and/or ionic strength on talin's actin crosslinking ability appears due to the 
effect on the interaction between actin and talin, and not on talin's ability to self-associate. 
Resuhs of electron microscopy demonstrated that even with very short polymerization times 
talin crosslinked actin filaments into both networks and bundles, without restricting the 
length of actin filaments in comparison to control F-actin. They also showed that talin 
crosslinked preformed actin filaments as well as it did actin filaments polymerized in its 
presence. The 190 kDa calpain generated fi-agment of talin had the ability to crosslink actin 
filaments into both networks and bundles. However, it required a slightly lower pH than did 
intact talin to effectively crosslink actin filaments into both networks and bundles. 
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Introduction 
Talin is a protein localized primarily at cell-matrix attachment sites where actin filaments 
are attached to the cell membrane. Because early studies indicated no direct talin-actin 
interaction (Burridge and Mangeat, 1984), it was suggested, based primarily on in vitro 
protein binding studies, that talin was one component involved in a multi-protein bridge that 
included integrin, talin, vinculin, a-actinin, and actin that links the actin filament-based 
cytoskeleton to the cytoplasmic face of the cell membrane (Burridge et al ., 1988). Afler a 
direct interaction in vitro between talin and actin was shown (Muguruma et al., 1990), a 
more direct role for talin in linking the cytoskeleton to the cell membrane was proposed 
(Simon et al., 1991). However, the nature of the talin-actin interaction reported by different 
labs has varied considerably. Kaufmann et al. (1991), for instance, reported that talin 
promoted the nucleation of actin filaments by binding to G-actin, and that talin decreased the 
viscosity of F-actin solutions. Muguruma et al. (1990, 1992), however, reported that talin 
increased the viscosity of F-actin solutions. Schmidt et al. (1993) showed that talin has the 
ability to cosediment with actin filaments and to increase the viscosity of F-actin solutions, 
and that this ability is enhanced by lowering the pH and ionic strength. As discussed in the 
previous chapter of this dissertation, my results obtained by electron microscopy have 
offered an explanation for the direct interaction between talin and actin filaments measured 
by the cosedimentation and viscometry assays (Schmidt et al., 1993) by showing that talin 
crosslinks actin filaments into both networks and bundles at pH 6.4 and low ionic strength. 
Talin can be catalytically cleaved by a variety of proteases, including the calpains 
(Beckerle et al., 1986), into two prominent proteolytic fragments of 47 kDa [the N-terminal 
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head domain containing residues 1-434 (Rees et al., 1990)] and ~ 190 kDa [the C-terminal 
tail domain containing residues 435-2541 (Rees et al., 1990)]. The ~ 190 IcDa fragment has 
been shown to interact with actin filaments, whereas the 47 kDa fragment does not 
(Muguruma et al., 1990, 1995). 
The objectives of this study were to examine the effects of selected factors, such as pH, 
ionic strength, actin polymerization time, and presence of intact vs. the 190 kDa talin 
fragment, on the interaction between talin and actin filaments. 
Experimental Procedures 
Protein Preparation - Talin was purified from turkey gizzard smooth muscle by the 
method of Schmidt et al. (1993) and Schmidt (1994), and was in a buffer containing 10 mM 
imidazole, pH 7.0, 0.1 mM PMSF', 1 ng/ml E-64, and 0.5 mM MCE. Actin was purified 
from porcine skeletal muscle as described in Schmidt et al. (1993), and was in a buffer 
containing 2 mM Tris-HCl, pH 8.0, 0.2 mM ATP, 0.2 mM CaClj, and 0.5 mM MCE. 
Protein concentrations were determined by the modified Lowry method (Sigma). The 
purified 190 kDa fragment of talin was prepared as described in Schmidt (1994). 
'The abbreviations used: EDC, l-ethyl-3-(3-dimethylaminopropyl) carbodiimide; EGTA, 
ethylene glycol bis (P-amino-ethyl ether) N,N,N',N', tetraacetic acid; MCE, 2-
mercaptoethanol; PMSF, phenylmethylsulfonyl fluoride; SDS-PAGE, sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis. 
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Electron Microscopy - Talin (0.10 mg/ml final concentration) and G-actin (0.25 mg/ml 
final concentration) were mixed in buffer A (10 mM imidazole-HCl, 1 mM ATP, 1 mM 
EGTA) at selected pH values at 25° C. Actin polymerization was then induced by addition of 
either MgClz (2 mM final concentration) or MgClj (2mM final concentration) plus selected 
concentrations of KCl. After incubation for 1 h at 25° C, samples of actin control and of the 
talin-actin mixture were negatively stained with 2% uranyl acetate, and were observed with a 
JEOL-100 CXII electron microscope operated at 80 kV as described in Schmidt et al. 
(1993), with representative areas photographed. 
Chemical Crosslinking - Talin (0.20 mg/ml) samples in buffer A containing 2 mM 
MgClj, or 2 mM MgClj and 100 mM KCl, at pH values of 6.4, 6.9, or 7.3 at 25° C were 
each crosslinked with EDC (40 mM final concentration). Aliquots were taken at specific 
time points and the reaction was quenched with 40 mM glycine, 40 mM Tris-HCl, pH 8.0 
(final concentration). The samples were analyzed by SDS-PAGE (Laemmli, 1970). 
Results 
The Effect ofpH and Ionic strength on the Interaction between Talin and Actin 
Filaments - Highly homogeneous talin and actin (Fig. 1) were used to examine the ability of 
talin to crosslink actin filaments at different pH values by using negative staining (Fig. 2). 
The actin filament controls at pH 6.4, 6.9, and 7.3 (Fig. 2A, 2C, and 2E, respectively) 
appeared similar, with long single filaments randomly dispersed. At pH 6.4, talin crosslinked 
actin filaments into both networks (NW) and bundles, including thin sheet-like bundles 
Fig. 1. Analysis of purified talin and actin by SDS-PAGE. Lane 1, 5 |ag actin; lane 2, 5 
Hg talin, T = talin, A = actin. 
1 2 
Fig. 2. Effect of pH on the ability of talin to crosslink actin filaments as shown by 
electron microscopy. Actin (0.25 mg/ml final concentration) was polymerized in the 
absence or presence of talin (0.10 mg/ml final concentration) by the addition of 2 mM MgClj 
(final concentration) at pH 6.4, 6.9, or 7.3. All samples were incubated for 1 h at 25°C and 
negatively stained. (A) Actin control polymerized at pH 6.4; (B) actin polymerized in the 
presence of talin at pH 6.4. TSB = thin-sheet like bundle, TB = tight bundle, NW = network; 
(C) actin control polymerized at pH 6.9; (D) actin polymerized in the presence of talin at pH 
6.9. TRA = talin-rich actin filaments, BA = bare actin filaments; (E) actin control 
polymerized at pH 7.3; (F) actin polymerized in the presence of talin at pH 7.3. Bar = 100 
nm in A-F. 
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(TSB) and tight bundles (TB) (Fig. 2B). The thin sheet-like bundles have an ordered two-
dimensional appearance (Fig. 2B), which has been discussed in the previous chapter of this 
dissertation. At pH 6.9, the ability of talin to crosslink actin filaments decreased, as shown 
by the presence of fewer bundles and less tight networks (Fig. 2D). The appearance of the 
bundles formed at pH 6.9 also was different from the bundles formed at pH 6.4 by having 
alternating talin-rich actin filament areas (TRA) and bare actin filament areas (BA), as was 
also discussed in the previous chapter of the dissertation. At pH 7.3, talin's crosslinking 
activity is nearly absent (Fig. 2F), with no bundles present, and only slightly crosslinked 
networks evident. These results showed that talin's ability to crosslink actin filaments into 
both networks and bundles was very pH dependent, being stronger at low pH and weaker as 
pH was increased. 
To examine the effect of ionic strength on the ability of talin to crosslink actin filaments, 
different concentrations of KCl were present when actin polymerization was initiated (Fig. 
3). The actin filament controls polymerized at pH 6.4 in the presence of 25 mM KCl (Fig. 
3A) or 75 mM KCl (Fig. 3C) appeared similar to those formed in the absence of KCl (Fig. 
2A). As was shown in Fig. 2B, at pH 6.4 and low ionic strength, talin crosslinked actin 
filaments extensively into networks and bundles. However, at pH 6.4 with 25 mM KCl 
present, talin's ability to crosslink actin filaments was decreased considerably as shown by 
the presence of fewer bundles and less highly crosslinked networks (Fig. 3B). The thin sheet­
like bundles seen at pH 6.4 with no KCl present (Fig. 2B) were absent, and those bundles 
present (Fig. 3B) appeared similar to the tight bundles formed with no KCl present (Fig. 
Fig. 3. Efiect of ionic strength on the ability of talin to crosslink actin filaments at pH 
6.4 as shown by electron microscopy. Actin (0.25 mg/ml final concentration) was 
poljTnerized in the absence or presence of talin (0.10 mg/ml final concentration) by the 
addition of 2 mM MgClj (final concentration) and selected concentrations of KCl at pH 6,4. 
All samples were incubated for 1 h at 25°C and negatively stained. (A) actin control 
polymerized with 2 mM MgCIz and 25 mM KCl; (B) actin in the presence of talin 
polymerized with 2 mM MgClj and 25 mM KCl. TB = tight bundle, NW = network; (C) 
actin control polymerized with 2 mM MgClj and 75 mM KCl; (D) actin in the presence of 
talin polymerized with 2 mM MgClz and 75 mM KCl. Bar = 100 nm in A-D. 
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2B). At pH 6.9 with 75 mM KCl present, no bundles were present, but talin retained some 
of its ability to crosslink actin filaments into networks (Fig. 3D). 
Chemical Crosslinking of Talin - To determine whether talin was present as a monomer 
or dimer under the conditions used to examine the talin-actin interaction herein, the zero-
length chemical crosslinker, EDC, was used to crosslink talin (Fig. 4). At pH 6.4, after 10 
min of crosslinking in the absence or presence of 100 mM KCl, a band corresponding to an 
~ 400 kDa protein (D) was present (Fig. 4, lanes b). With increased crosslinking time, the 
amount of this band increased concomitantly with a decrease in the amount of the talin 
monomer band (M) (~ 225 kDa) in the absence or presence of 100 mM KCl (Fig. 4, lanes c-
e). Similar qualitative results also were observed at both pH 6.9 and 7.3, with or without 100 
mM KCl present (Fig. 4). The delay in the disappearance of talin monomers and 
simultaneous increase in dimers with increasing pH (especially noted at pH 7.3) is believed 
due to the reduced efficiency of EDC at higher pH (Hoare and Koshland, 1967). I observed 
much more conversion of monomer to dimer when I extended the crosslinking time to 4 h, 
or increased the EDC concentration (resuhs not shown). Taken in toto, the results indicated 
that talin was present primarily as a dimer and, thus, the effect of pH and ionic strength on 
talin's ability to crosslink actin filaments appears due to an effect on the talin-actin interaction 
instead of an effect on talin's self-association properties. Similar conclusions indicating that 
native talin consists of two subunits were found by Muguruma et al. (1992) and Goldmann 
et al. (1994). 
Fig. 4. Chemical crosslinking of talin by EDC. Aliquots of talin reaction mixtures (pH 
6.4, 6.9, or 7.3, without or with 100 mM KCl present) were taken at specific time points, 
quenched, and analyzed by SDS-PAGE. Lane a, talin before addition of EDC; lanes b, c, d, 
and e, are after addition of EDC and represent 10, 30, 60, and 120 min of crosslinking, 
respectively. M = talin monomer; D = talin dimer corresponding to an ~ 400 kDa protein. 
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The Effect of Polymerization Time on the Talin-Actin Interaction - To examine the 
ability of talin to crosslink actin filaments after very short polymerization time, actin was 
polymerized in the presence of talin at pH 6.4 and 25° C for only 5 min. As shown in Fig. 
5A, long randomly dispersed actin filaments were already formed in the absence of talin. And 
talin extensively crosslinked actin filaments into both networks and bundles (Fig. 5B). The 
bundles formed at S min were similar in appearance to the bundles examined after 
polymerization for 1 h (Fig. 2B). There also was no significant increase in shorter actin 
filaments found in talin-actin mixtures (Fig. 5B) in comparison to the actin filament control 
(Fig. 5A). Overall, these results indicated that talin's ability to crosslink actin filaments into 
both networks and bundles was not significantly affected by the actin polymerization time. 
The Ability of Talin to Crosslink Preformed Actin Filaments - The ability of talin to 
crosslink preformed actin filaments was examined by first polymerizing actin filaments in the 
absence of talin at pH 6.4 for 1 h, before talin was added to the actin filament solution and 
incubated for another 1 h. Talin crosslinked the preformed actin filaments into both networks 
and bundles (Fig. 6C) to an extent similar to that observed when actin was polymerized in 
the presence of talin for 1 h (Fig. 6B). Furthermore, the bundles shown in Fig. 6C are 
generally similar in appearance to those formed when actin was polymerized in the presence 
of talin for 1 h (Fig. 6B). These results suggest that talin clearly interacts with F-actin, and 
crosslinks existing actin filaments into networks and bundles. 
The Interaction Between the ~ 190 kDa Talin Fragment and Actin Filaments - The 
ability of the 190 kDa fragment of talin to crosslink actin filaments was examined by using 
negative staining (Fig, 7). At pH 6.4 and low ionic strength, intact talin extensively 
Fig. 5. Effect of short polymerization time on the ability of talin to crosslink and 
bundle actin filaments at pH 6.4 as shown by electron microscopy. Actin (0.25 mg/ml 
final concentration) was polymerized in the absence or presence of talin (0.10 mg/ml final 
concentration) by the addition of 2 mM MgClj (final concentration) for 5 minutes at 25° C 
and inrunediately negatively stained. (A) Actin control; (B) actin polymerized in the presence 
of talin. B = bundle, NW = network. Bar = 100 nm for A and B. 

Fig. 6. Ability of talin to crosslink preformed actin filaments at pH 6.4 as shown by 
electron microscopy. (A) Preformed actin (0.25 mg/ml final concentration) control 
polymerized by the addition of 2 mM MgClj (final concentration); (B) Actin (0.25 mg/ml 
final concentration) was polymerized in the presence of talin (0.10 mg/ml final 
concentration) by the addition of 2 mM MgClj (final concentration); (C) Talin (0.10 mg/ml 
final concentration) was added to preformed actin filaments (0.25 mg/ml final concentration) 
that had been polymerized by the addition of 2 mM MgClj (final concentration) for 1 h. B = 
bundle, NW = network. Bar = 100 nm for A-C. 

Fig. 7. Effect of pH on the ability of the 190 kDa talin fragment to crosslink actin 
filaments as shown by electron microscopy. Actin (0.25 mg/ml final concentration) was 
polymerized in the absence or presence of talin (0.10 mg/ml final concentration) or of the 
190 kDa talin fragment (0.10 mg/ml final concentration) by the addition of 2 mM MgClj 
(final concentration) at pH 6.4 or 6.0. All samples were incubated for 1 h at 25° C and 
negatively stained. (A) Actin control at pH 6.4; (B) actin polymerized in the presence of 
intact talin at pH 6.4; (C) actin polymerized in the presence of 190 kDa talin fragment at pH 
6.4; (D) actin control at pH 6.0; (E) actin polymerized in the presence of 190 kDa talin 
fragment at pH 6.0. B = bundle, NW = network. Bar = 100 nm for A-E. 
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crosslinked actin filaments into both networks and bundles (Fig.TB; also see Figs. 2B and 
6B). As shown in Fig. 7C, the 190 kDa talin fragment had the ability to form actin networks, 
but did not exhibit any actin bundling activity at pH 6.4 and low ionic strength. When the 
actin crosslinking ability of the 190 kDa talin fi-agment was tested at pH 6.0, it crosslinked 
actin filaments into both networks and bundles (Fig. 7E) to a similar extent as did intact talin 
at pH 6.4 (Fig. 7B). However, the bundles formed in the presence of the 190 kDa talin 
fragment at pH 6.0 did not exhibit any obvious longitudinal periodicity in comparison to 
some of the bundles formed at pH 6.4 with intact talin (Fig. 7B; also see Figs. 2B and 6B). 
These results suggest that the 190 kDa talin fragment possesses the actin binding activity 
responsible for its actin filament crosslinking activity. 
Discussion 
Although independent research groups have reported a direct interaction in vitro 
between talin and actin filaments (Muguruma, et al., 1990, 1992, 1995; Kaufmann et al., 
1991; Schmidt et al., 1993; Goldmann et al., 1994), the mode of the talin-actin interaction 
varies considerably among the labs. For instance, talin reportedly nucleates actin 
polymerization, and decreases the viscosity of F-actin solutions (Kaufmann et al., 1991; 
Goldmann et al., 1994), or it increases the viscosity of F-actin solutions and cosediments 
with F-actin (Muguruma et al., 1990, 1992; Schmidt et al., 1993). And, although the 
increase in the viscosity of F-actin solutions and the cosedimentation assays indicate an actin 
crosslinking activity for talin (Muguruma et al., 1990, 1992, 1995), no actin filament 
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crossHnking by talin was observed by electron microscopy by that laboratory (Muguruma et 
al., 1990). In our laboratory, talin has been identified as an actin filament crossHnking 
protein, especially at pH 6.4 and low ionic strength, and talin's crossHnking activity as 
measured by cosedimentation and viscometry assays is pH and ionic strength dependent, 
being decreased with increasing pH and/or ionic strength (Schmidt et al., 1993). As I 
demonstrated herein (and see previous chapter in this dissertation) talin crosslinks actin 
filaments into both networks and bundles, and these crossHnking abilities are pH and ionic 
strength dependent. Thus, I have provided a structural basis for results of the talin-actin 
cosedimentation and viscometry assays we reported earlier (Schmidt et al., 1993). 
The results shown herein that talin crosslinked actin filaments into both networks and 
bundles after only five minutes of polymerization, without showing a significant number of 
shorter actin filaments compared to the F-actin controls, disagree with the reports of 
Kaufmann et al. (1991) and Goldmann et al. (1994) in which they suggested that talin 
decreases viscosity of actin filaments because it nucleates actin polymerization and increases 
the number of filaments but decreases their length. As shown herein, talin also crosslinked 
preformed actin filaments in a fashion similar to what it did when actin filaments were 
formed in its presence. These results clearly show that talin interacts with F-actin, which 
disagrees with the suggestion in Kaufinann et al. (1991) that talin has no effect on preformed 
actin filaments. The reason(s) for the variable observations on talin's ability to interact with 
actin reported by different research groups may be due, in part, to the different preparation 
procedures used to prepare talin, which, in turn, may result in different degrees of purity 
(Muguruma et al., 1990, 1992; Kaufmann et al., 1991; Schmidt et al., 1993; Goldmann et al.. 
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1994). Also, the ionic conditions used in the experiments conducted in different labs may be 
responsible for some of the different results reported, especially since we have found the 
talin-actin interaction to be very sensitive to both pH and ionic strength. 
To crosslink actin filaments, it appears that talin has either two or more actin binding 
domains, or one actin binding domain and the ability to self-associate. The actin binding 
activity of talin is contained in the 190 kDa fi'agment generated by calpain or other proteases 
(Muguruma et al., 1990, 1995; Niggli et al., 1994). However, neither the number nor the 
location of the specific actin binding domain(s) in the 190 kDa talin fragment has been 
identified. It was recently reported that platelet talin exists as an anti-parallel homodimer 
(Goldmann et al., 1994), although the reported size and shape of native talin varies 
considerably (e.g.. Collier and Wang, 1982; Molony et al., 1987; Schmidt et al., 1993). The 
results of the chemical crosslinking experiments herein indicated that talin exists primarily as 
a dimer under the conditions of pH and ionic strength tested, which suggests the major effect 
of pH and ionic strength on talin's actin filament crosslinking activity is due to the direct 
talin-actin interaction rather than on talin's ability to self-associate. 
The 190 kDa talin fragment was shown to have the ability to crosslink actin filaments 
into both networks and bundles. However, it required a slightly lower pH than did intact 
talin. This indicates that the actin binding site(s) in talin that are responsible for its 
crosslinking activity is located on the 190 kDa fi-agment. Muguruma et al. (1990, 1995) have 
reported that the 47 kDa head fragment of talin does not cosediment with actin filaments. As 
shown herein, the 190 kDa talin tail fragment did not form as highly ordered actin bundles as 
did intact talin. Perhaps the 47 kDa N-terminal fragment in some way regulates the actin 
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binding site(s) on the 190 kDa fragment. 
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EFFECT OF PHOSPHOINOSITIDES ON THE TALIN-ACTIN INTERACTION 
A paper to be submitted to the Journal of Biological Chemistry 
Jinwen Zhang, Richard M. Robson, and Marvin H. Stromer 
Summary 
Talin is a membrane-cytoskeleton linking protein primarily located in cell-matrix type 
adherens junctions. Talin has been shown to cosediment with F-actin, increase low shear 
viscosity of F-actin solutions, and crosslink actin filaments into networks and bundles at pH 
6.4 and low ionic strength. In this study, the effects of phospholipids on the interaction 
between talin and actin filaments were examined by using cosedimentation and viscometry 
assays, and electron microscopy. The results showed that of the phospholipids tested, the 
phosphoinositides, including phosphatidylinositol 4,5-bisphosphate (PIP2'), 
phosphatidylinositol 4-phosphate (PIP), and phosphatidylinositol (PI) bind talin in the form 
of talin/phosphoinositide complexes and thereby prevent talin from effectively interacting 
v^dth actin filaments at pH 6.4 and low ionic strength. Under the same ionic conditions, 
phosphatidylserine (PS), phosphatidylcholine (PC), and inositol 1,4,5-trisphosphate (IP3) did 
'The abbreviations used are: PIPj, phosphatidylinositol 4,5-bisphosphate; PIP, 
phosphatidylinositol 4-phosphate; PI, phosphatidylinositol; PS, phosphatidylserine; PC, 
phosphatidylcholine; IP3, inositol 1,4,5-trisphosphate; MCE, 2-mercaptoethanol; PMSF, 
phenylmethylsulfonyl fluoride; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis. 
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not significantly affect the talin-actin interaction. Talin retained its ability to crosslink actin 
filaments when the phosphoinositide vesicle structures were disrupted with the detergent 
Triton X-100. Divalent cations such as Ca^^ significantly decreased the efficiency of the 
phosphoinositides in inhibiting the talin-actin interaction. 
Introduction 
Talin, a protein associated with the membrane regions specialized for cell-substrate 
contacts, has been shown to interact with actin in vitro (Muguruma et al., 1990, 1992; 
Kaufmann et al., 1991; Schmidt et al., 1993). Talin cosediments with actin filaments, 
increases the viscosity of F-actin solutions (Muguruma et al., 1990, 1992; Schmidt et al., 
1993), and crosslinks actin filaments into both networks and bundles (Zhang et al., 1995). 
The predicted primary structure of talin from cDNA sequence analysis (Rees et al., 1990) 
showed that talin shares an ~ 200 amino acid sequence homologous to several other 
proteins, such as protein 4.1, ezrin, moesin (Lankes and Furthmayr, 1991), and a human 
protein-tyrosine phosphatase (PTPHl) (Yang and Tonks, 1991) at their N-terminal regions. 
The homologous N-terminal portion of protein 4.1 has been assigned an important role in 
linking the cytoskeleton to the cell membrane (reviewed in Luna and Hitt, 1992), and the 
homologous region of the N-terminal portion of talin may likewise be important in 
membrane binding (Rees et al., 1990). The interactions identified between talin and the 
transmembrane glycoprotein, integrin (Horwitz et al., 1986), and between talin and actin 
(Muguruma et al., 1990, 1992; Kaufmann et al., 1991) led to the suggestion that talin is 
directly involved in linking the actin-based cytoskeleton and the cell membrane (Simon et al., 
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1991). Talin's actin binding activity is associated with the large (-190 kDa) C-terminal tail 
fragment of talin (Muguruma et al., 1990, 1995, Niggli et al., 1994). 
Previous studies have indicated that talin binds to acidic phospholipids (Heise et al., 
1991; Goldmann et al, 1992, Dietrich et al., 1993). By using proteolytic fragments of talin, 
the 47 icDa N-terminal fragment, and not the ~ 190-200 kDa C-terminal fragment, of talin 
has been shown to possess these phospholipid binding properties (Niggli et al., 1994; 
Muguruma et al., 1995). 
The effect of phosphoinositides, components of the PI signal transduction pathway 
(Berridge and Irvine, 1989), on several actin-binding proteins has been shown (Isenberg, 
1991; Janmey, 1994). Phosphoinositides inhibit the interactions between actin and a number 
of actin-binding proteins such as profilin (Lassing and Lindberg, 1985, 1988), gelsolin 
(Janmey and Stossel, 1987, 1989; Janmey et al., 1992 ), CapZ (Heiss and Cooper, 1991), 
and filamin (Furuhashi et al., 1992) by interacting with the actin-binding proteins rather than 
the actin (Isenberg, 1991; Janmey, 1994). a-Actinin is an exception, in that it has been 
shown that the phosphoinositides PIPj, PIP, and PI increased its actin gelating activity at low 
concentrations, but inhibited this activity at higher concentrations (Fukami et al., 1992). The 
effect, if any, of the phosphoinositides on the talin-actin interaction has not been shown. The 
objective of this study was to investigate the effect of specific phospholipids, especially the 
phosphoinositides, on the talin-actin interaction. The results indicate that phosphoinositides 
bind to talin and thereby inhibit the interaction between talin and actin. 
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Experimental Procedures 
Protein Preparation - Smooth muscle talin was prepared from turkey gizzards as 
described (Schmidt et al., 1993; Schmidt, 1994). Purified talin was in a buffer containing 10 
mM imidazole, pH 7.0, 0.1 mM PMSF, 1 ng/ml E-64, and 0.5 mM MCE. Actin was purified 
from porcine skeletal muscle as described in Schmidt et al. (1993), and in a buffer containing 
2 mM Tris-HCl, pH 8.0, 0.2 mM ATP, 0.2 mM CaClj, and 0.5 mM MCE. Protein 
concentrations were determined by using the modified Lowry method (Sigma). 
Lipids - Phospholipids including PIPj, PIP, PI, PS, and PC, and another related 
compound, IP3, were purchased from Sigma and used without further purification. All were 
dissolved (1 mM final concentration) in double-distilled, deionized water, sonicated until the 
solution was clear or homogenous, and aliquots were then stored at -70° C. The 
phospholipids were thawed at room temperature and sonicated for 1 min on ice immediately 
before use. 
Cosedimentation Assay - Talin (0.20 mg/ml final concentration) was incubated with 
specific phospholipids at selected molar ratios at 25° C for 30 min in buffer A (10 mM 
imidazole, pH 6.6, 1 mM ATP). G-actin (0.50 mg/ml final concentration) was then added 
and polymerization induced by the addition of MgClz (2 mM final concentration). The final 
pH was 6.4. After incubating for 1 h at 25° C, the samples were centrifiiged at 110,000 x g 
for 20 min in a Beckman airflige. Comparable amounts of the supematants and pellets were 
analyzed by SDS-PAGE (Laemmli, 1970). Specific incubation conditions were tested and 
will be given in the Figure Legends. The figures shown are representative of results (with 
each experiment run at least in duplicate) obtained from a minimum of three different talin 
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and actin preparations. 
Low Shear Viscometry - Talin (0.10 mg/ml final concentration) was incubated with 
specific phospholipids at selected molar ratios at 25° C for 30 min in buffer A. G-actin (0.2S 
mg/ml final concentration) was then added and polymerization induced by addition of MgClj 
(2 mM final concentration). The final pH was 6.4. The low shear viscosity of the samples 
was measured as described (Schmidt et al., 1993). Results were expressed as normalized 
viscosities, obtained by dividing all actin/talin viscosity values by actin control viscosity 
values, and actin/talin/phospholipid viscosity values by actin/phospholipid control viscosity 
values. A normalized value of one indicates no change in viscosity from the control. Specific 
incubation conditions were tested and will be given in the Figure Legends. The viscosity 
experiments were done at least in duplicate, and the values reported represent the means 
obtained fiom three different talin and actin preparations. 
Electron Microscopy - Talin (0.10 mg/ml final concentration) was first incubated with 
specific phospholipids at 25° C for 30 min in buffer A. G-actin (0.25 mg/ml final 
concentration) was then added and polymerization was induced by the addition of MgClz (2 
mM final concentration). The final pH was 6.4. After 1 h of polymerization at 25° C, the 
samples were negatively stained and examined as described (Schmidt et al., 1993; Zhang et 
al., 1995). Specific incubation conditions were tested and will be given in the Figure 
Legends. 
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Results 
The Effect of Phospholipids on the Interaction Between Talin and Actin - The effect of 
phospholipids on the talin-actin interaction at pH 6.4 and low ionic strength was examined 
by cosedimentation assays (Figs. I and 2). At pH 6.4 and low ionic strength, talin bound and 
cosedimented with actin filaments by centrifugation (Fig. 1, panel c) as shown previously 
(Schmidt et al., 1993), while talin in the absence of actin remained in the supernatant (Fig. 1, 
panel b). As shown in Fig. 1 (panels d, f, and h), however, a significant proportion (> one-
half) of talin in the absence of actin sedimented in the presence of PIPj. o*" PI. indicating 
formation of large talin/phosphoinositide complexes. As a result, the talin observed in the 
pellets of the actin/talin/phosphoinositide mixtures (Fig. 1, panels e, g, and i) can be due to a 
combination of formation of the complexes of phosphoinositides and talin, and to the binding 
between talin and actin filaments. It is evident in Fig. 1, in the presence of the 
phosphoinositides, that more talin is sedimented with the actin present (panels e, g, and i) 
than in its absence (panels d, f, and h). The PIPj, PDP, and PI used at this concentration 
(molar ratio of 20 phosphoinositides to one 225 kDa talin) did not affect the amount of 
control actin filaments sedimented (results not shown). As shown previously, the interaction 
between talin and actin is markedly pH and ionic strength dependent (Schmidt et al.,1993; 
Zhang et al., 1995), with increase of pH and/or ionic strength effectively decreasing the talin-
actin interaction. The addition of the phosphoinositides at the concentrations used herein did 
not change the pH of the interaction solutions (results not shown), and the concentration of 
the phosphoinositides (< 1 mM) was not high enough to significantly alter ionic strength and 
Fig. 1. Eflect of phosphoinositides on the ability of talin to cosediment with actin 
filaments at pH 6.4. Talin (0.20 mg/ml final concentration) was first incubated with PIPj, 
PIP, or PI, when present, at a molar ratio of 20 phosphoinositides to one talin in buffer A for 
30 min at 25° C. G-actin (0.50 mg/ml final concentration) was then added, and 
polymerization initiated by the addition of 2 mM MgClz (final concentration). All samples 
were incubated, centrifliged, and assayed as described in Experimental Procedures, (a) Actin 
control; (b) talin control; (c) actin/talin; (d) talin/PIPj control; (e) actin/talin/PIPj; (f) 
talin/PIP control; (g) actin/talin/PIP; (h) talin/PI control; (i) actin/talin/PI. PL = 
phospholipid, T = talin, A = actin, s = supernatant, p = pellet. 
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Fig. 2. Eflect of phosphatidylserine (PS), phosphatidylcholine (PC), and inositol 1,4,5-
trisphosphate (IP3) on the ability of talin to cosediment with actin filaments at pH 6.4. 
Talin (0.20 mg/ml final concentration) was first incubated with PS, PC, or IP3 at a molar 
ratio of 40 phospholipids or IP3 to one talin in buffer A for 30 min at 25° C. G-actin (0.50 
mg/ml final concentration) was then added, and polymerization initiated by the addition of 2 
mM MgClj (final concentration). All samples were incubated, centrifuged, and assayed as 
described in Experimental Procedures, (a) Actin/PS control; (b) talin/PS control; (c) 
actin/talin/PS; (d) actin/PC control; (e) talin/PC control; (f) actin/talin/PC; (g) actin/IPj 
control; (h) talin/IPj; control; (i) actin/talin/IPj. T = talin, A = actin, s = supernatant, p = 
pellet. 
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the talin-actin interaction (Schmidt, 1994). Addition of PS, an acidic phospholipid, PC, a 
neutral phospholipid, or IP3, one of the hydrolysis products of PIP2, did not aflFect the talin-
actin interaction under the same ionic condition, even at higher concentrations (molar ratio 
of 40 to 1 talin) (Fig. 2), with the gel patterns appearing essentially the same as in the 
absence of phospholipids for the control actin, control talin, and control actin/talin mixture in 
Fig. 1 (panels a, b, and c, respectively). The results shown in Figs. 1 and 2 showed that of 
the phospholipids tested, only the phosphoinositides had an ability to affect the 
sedimentation behavior of talin. 
The effect of phosphoinositides on the talin-actin interaction was also examined by low 
shear viscometry. We have previously shown that at pH 6.4 and low ionic strength, talin 
dramatically increases the viscosity of F-actin solutions (Schmidt et al., 1993). The increase 
in viscosity was sufficiently high in the present study (molar ratio of one 225 kDa talin to 13 
42 kDa actins) that the ball would not travel through the solution inside the capillary tube, 
and is defined herein as "gel". As shown in Fig. 3, the ability of talin to increase the viscosity 
of F-actin solutions was inhibited when talin was preincubated with phosphoinositides for 30 
min before actin was added and polymerization initiated by addition of MgClj. In the absence 
of phosphoinositides, talin gelated the F-actin solutions. As the molar ratio of the 
phosphoinositides (PIP2, PIP, or PI) to talin was increased, the ability of talin to increase the 
viscosity of F-actin solutions was decreased. Among the three phosphoinositides, PI and 
PIP2 were somewhat more effective than PIP in inhibiting talin's ability to increase the 
viscosity of F-actin solutions. However, at a molar ratio of 30:1 (phosphoinositide to talin). 
Fig. 3. Effect of phosphoinositides on the ability of talin to increase the low shear 
viscosity of F-actin solutions at pH 6.4. Talin (0.10 mg/ml final concentration) was first 
incubated with PIP2, PIP, or PI, when present, in buffer A for 30 min at 25° C. G-actin (0.25 
mg/ml final concentration) was then added, and polymerization initiated by the addition of 2 
mM MgClj (final concentration). The viscosities of all samples were measured and expressed 
as normalized viscosities as described in Experimental Procedures. 
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all three phosphoinositides totally inhibited talin's ability to increase the viscosity of F-actin 
solutions. None of the phosphoinositides affected the viscosity of F-actin controls (results 
not shown), indicating that phosphoinositides affect the talin-actin interaction by interacting 
with talin but not actin. In contrast to the phosphoinositides, the presence of PS, PC, or IP3 
did not inhibit the ability of talin to increase the viscosity of F-actin solutions (Fig. 4), even 
at higher concentrations than those of the phosphoinositides used in the previous assays (Fig, 
3). The viscosity results shown in Figs. 3 and 4 are consistent with the results obtained from 
the cosedimentation assays (Figs. 1 and 2). 
The results shown in Figs. 1 and 3 were from experiments that included preincubation of 
talin and the phosphoinositides before addition of G-actin and polymerization. The effect of 
the presence of G-actin during the preincubation period, before polymerization, on the 
interaction between talin and phosphoinositides was examined by incubating talin, G-actin, 
and phospholipids at pH 6.4 and low ionic strength for 30 min at 25° C, before 
polymerization was initiated by adding MgCl2. The results of low shear viscometry assays 
shown in Fig. 5 are similar to those shown in Fig, 3, indicating that PIP2, PIP, or PI inhibited 
ability of talin to increase the viscosity of F-actin solutions, regardless of the presence of G-
actin during the preincubation period. 
As shown in Fig, 6, and as we have shown previously (Zhang et al., 1995), talin 
crosslinks actin filaments into both networks and bundles (B) at pH 6.4 and low ionic 
strength. As shown in Fig, 7, preincubation of the talin with PIP2, PEP, or PI for 30 min at 
25° C before G-actin was added and polymerization initiated by the addition of MgClj, under 
Fig. 4. EfTect of phosphatidylserine (PS), phosphatidylcholine (PC), and inositol 1,4,5-
trisphosphate (IP3) on the ability of talin to increase the low shear viscosity of F-actin 
solutions at pH 6.4. Talin (01.0 mg/ml final concentration) was first incubated with PS, PC, 
or IP3, when present, in buffer A for 30 min at 25° C before G-actin (0.25 mg/ml final 
concentration) was added, and polymerization initiated by the addition of 2 mM MgClj (final 
concentration). The viscosities of all samples were measured and expressed as normalized 
viscosities as described in Experimental Procedures. 
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Fig. 5. EiTect of presence of G-actin on the interaction between talin and 
phosphoinositides during preincubation period prior to actin polymerization as 
measured by low shear viscometry of F-actin solutions at pH 6.4. Talin (0.10 mg/ml final 
concentration), phosphoinositides, when present, and G-actin (0.25 mg/ml final 
concentration) were mixed together for 30 min at 25° C before MgClj (2 mM final 
concentration) was added to initiate actin polymerization. The viscosities of all samples 
were measured and expressed as normalized viscosities as described in the Experimental 
Procedures. 
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Fig. 6. The ability of talin to crosslink actin filaments at pH 6.4 as shown by electron 
microscopy. Actin (0.25 mg/ml final concentration) was polymerized in the absence or 
presence of talin (0.10 mg/ml final concentration) by the addition of 2 mM MgClj (final 
concentration) at 25° C. All samples were incubated for 1 h and negatively stained as 
described in Experimental Procedures. (A) Actin control; (B) actin polymerized in the 
presence of talin. Globular particles often were observed at the points of filament 
intersection (small arrows) in networks. B = bundle. Bar = 100 nm for A and B. 

Fig. 7. Effect of phosphioinositides on the ability of talin to crosslink actin filaments at 
pH6.4 as shown by electron microscopy. Talin (0.10 mg/m] final concentration) was first 
incubated with PIPj, PIP, or PI for 30 min at 25° C. G-actin (0.25 mg/ml final concentration) 
was then added, and polymerization initiated by the addition of 2 mM MgCl2 (final 
concentration). Samples were negatively stained as described in Experimental Procedures. 
(A) PIPj/actin (20:13) control; (B) PIP/actin (20:13) control; (C) Pl/actin (20:13) control; 
(D) PIPj/talin/actin (20:1:13); (E) PIP/talin/actin (20:1:13). B = bundle; (F) Pl/talin/actin 
(20:1:13); (G) PIPj/talin/actin (40:1:13); (H) PIP/talin/actin (40:1:13); (I) Pl/talin/actin 
(40; 1:13). Numbers within the parentheses are molar ratios. Bar = 100 nm for A-I. 
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the same ionic conditions as used for Fig. 6, inhibited the ability of talin to crosslink actin 
filaments at low concentrations of phosphoinositides and eliminated it at higher molar ratios 
of phosphoinositides to talin, Actin filament controls in the presence of PIP2, PIP, or PI (Fig. 
7A, 7B, and 7C, respectively) appeared randomly dispersed and similar to actin filament 
controls formed in the absence of the phosphoinositides (Fig. 6A), except for the presence of 
the phosphoinositide vesicles (Fig. 7A-C, arrows). The vesicles in the actin controls (Fig. 
7A-C) were similar in structure to those observed for each specific phosphoinositide in the 
absence of actin (results not shown). At a molar ratio of 20; 1 (phosphoinositides to talin), no 
bundles were observed in talin/PIPj/F-actin (Fig. 7D) or in talin/PI/F-actin mixtures (Fig. 
7F). Some shorter, thinner bundles, in comparison to the bundles formed in the absence of 
phosphoinositides, were found in talin/PIP/F-actin mixture (cf, Fig. 7E with Fig. 6B). These 
results were in concert with the results obtained from the viscometry assays (Fig. 3), in that 
PIP2 and PI were somewhat more effective than PIP in inhibiting the interaction between 
talin and actin filaments. As the bundles disappeared, a number of talin/phosphoinositide 
complexes were present (Fig. 7D and 7F, arrows). The complexes, such as those seen in 
Fig. 7D and 7F, appeared similar to those observed in talin/phosphoinositide mixtures 
examined in the absence of actin (results not shown). As the concentration of 
phosphoinositides was elevated (40 phosphoinositides to 1 talin), no bundles or networks 
were observed in the talin/PIPj/F-actin, talin/PIP/F-actin, or talin/PI/F-actin mixtures (Fig. 
7G, 7H, and 71, respectively), and large numbers of talin-phosphoinositide complexes were 
present (arrows). 
The presence of PS, PC, or IP3 did not affect either the polymerization of actin filaments 
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(cf, Fig. 8 A, 8C, and 8E with Fig. 6 A) or the ability of talin (molar ratio of 40 to 1 talin) to 
crosslink actin filaments, in that bundles and networks were observed (Fig. 8B, 8D, and 8F) 
as seen in the F-actin/talin mixture in the absence of phosphoinositides (cf, Fig. 8B, 8D, and 
8F with Fig. 6B). 
Taken together, the results of the cosedimentation assays, viscometry assays, and 
electron microscopy indicate that phosphoinositides interfere with the talin-actin interaction 
by binding to talin to form talin/phosphoinositide complexes, and thereby prevent talin from 
interacting with actin filaments. 
The Effect of Triton X-100 on the Activity of Phosphoinositides - To gain more evidence 
as to whether inhibition of the talin-actin interaction by phosphoinositides was due to the 
formation of talin/phosphoinositide complexes, PI, PIP, or PIPj was preincubated with 
0.5% Triton X-100 before talin was added. Even high concentrations of phosphoinositides 
no longer inhibited the talin-actin interaction as shown by both cosedimentation assays (Fig. 
9a) and viscometry assays (Fig. 9b). As shown in Fig. 9a, the presence of Triton X-100 had 
no effect on the sedimentation behavior of actin, talin, or talin/actin mixture (cf, Fig. 9a, 
panels a, b, and c with Fig. 1, panels a, b, and c). As shown in Fig. 9a, after preincubation 
with Triton X-100, the phosphoinositides (PI is shown) no longer had the ability to bind talin 
to form talin/phosphoinositide complexes and sediment as they did without the Triton X-100 
(cf, Fig. 9a, panel e with Fig. 1, panel h). These results indicate that phosphoinositide 
vesicles are necessary for forming complexes with talin, and thereby preventing talin from 
Fig. 8. EfTect of phosphatidylserine (PS), phosphatidylcholine (PC), and inositol 1,4,5-
trisphosphate (IP3) on the ability of talin to crosslink actin filaments at pH 6.4 as 
shown by electron microscopy. Talin (0.10 mg/tnl final concentration) was first incubated 
with PS, PC, or IP3 for 30 min at 25° C before G-actin (0.25 mg/ml final concentration) was 
added, and polymerization initiated by the addition of 2 mM MgClj (final concentration). 
Samples were negatively stained as described in Experimental Procedures. (A) PS/actin 
(40; 13); (B) PS/talin/actin (40:1:13); (C) PC/actin (40:13); (D) PC/talin/actin (40:1:13); (E) 
IPs/actin (40:13); (F) Pj/talin/actin (40:1:13). Numbers within the parentheses are molar 
ratios. B = bundle, NW = network. Bar = 100 nm for A-F. 

Fig. 9. Effect of Triton X-100 on the ability of phosphoinositides to inhibit the talin-
actin interaction at pH 6.4. When present, specific phosphoinositides were first incubated 
with 0.5% Triton X-100 (v/v) for 5 min before talin (0.10 mg/ml final concentration) was 
added, and incubated for another 30 min. G-actin (0,25 mg/ml final concentration) was then 
added and polymerization initiated by the addition of 2 mM MgClj (final concentration), 
a. Cosedimentation assay. All samples were incubated for 1 h at 25°C, centrifliged, and 
assayed as described in Experimental Procedures. 
(a) Triton X-lOO/actin control; (b) Triton X-lOO/talin control; (c) Triton X-lOO/talin/actin 
control; (d) Pi/Triton X-lOO/actin (30:13); (e) Pi/Triton X-lOO/talin (30:1); (f) Pi/Triton X-
lOO/talin/actin (30:1:13). Numbers within the parentheses are molar ratios of PI to talin 
and/or actin in the order listed. T = talin, A = actin, s = supernatant, p = pellet. 
Triton x-100 
a b c 
A  A  
Triton X-IOO/PI 
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Fig. 9 (continued) 
b. Viscometry assay. After incubation for 10 min at 25° C, the viscosities of all samples 
were measured and expressed as normalized viscosities as described in Experimental 
Procedures. 
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binding to actin filaments. 
The Effect of on Activities of Phospholipids - That only the phosphoinositides 
among the five amphipathic phospholipids tested (PIP2, PIP, PI, PS, and PC) affected the 
talin-actin interaction suggests that the inositol ring and/or the phosphate groups on the 
inositol ring may be important for their inhibitory action. However, that the hydrophilic IP3 
alone did not show any inhibitory effect suggests that the formation of vesicles by 
amphipathic phospholipids is important. To examine the importance of the phosphate groups 
in the phosphoinositides, the phosphoinositides were preincubated with 1 mM Ca^^ before 
talin was added. The results showed that the presence of 1 mM Ca^^ effectively suppressed 
the inhibitoiy effects of PI on the talin-actin interaction as shown by cosedimentation (Fig. 
10a). The presence of 1 mM Ca^^ did not affect the sedimentation of actin, talin, or 
talin/actin mixture controls (cf, FiglOa, panels a, b, and c with Fig. 1, panels a, b, and c). 
However, the PI was no longer able to bind talin and sediment in the form of talin/PI 
complexes when the PI was preincubated with Ca^^ (cf, Fig. 10a, panel e with Fig. 1, panel 
h). As shown in Fig. 10b, the preincubation of the phosphoinositides with 1 mM Ca^^ 
decreased their inhibitory effect on the talin-actin interaction as shown by low shear 
viscometry assays. Results of negative staining also showed that preincubation of 
phosphoinositides with 1 mM Ca^"^ prevented the phosphoinositides from blocking the 
formation of actin networks and bundles (cf, Fig. 10c, B with C). Although the Ca^"^ 
concentration (1 mM) used was sufficiently high to complex all phosphate groups in the 
phosphoinositides (< 0.1 mM), it did not completely suppress the inhibitory effect of 
Fig. 10. Eflect of Ca'* on tiie ability of phosphoinositides to inhibit the talin-actin 
interaction at pH 6.4. When present, specific phosphoinositides were first incubated with 1 
mM Ca^"^ (final concentration) for 5 min before talin (0.10 mg/ml final concentration) was 
added, and incubated for another 30 min. G-actin (0.25 mg/ml final concentration) was then 
added, and polymerization initiated with 2 mM MgCl^ (final concentration), 
a. Cosedimentation assay. All samples were incubated for 1 h at 25°C, centrifuged, and 
assayed as described in Experimental Procedures. 
(a) Ca^Vactin control; (b) Ca^V talin control; (c) Ca^Vtalin/actin control; (d) Ca^^/PI/actin 
(30; 13); (e) Ca^'^/PI/talin (30:1); (f) Ca^'^/PI/talin/actin (30.1:13). Numbers within the 
parentheses are molar ratios of PI to talin and/or actin in the order listed. T = talin, A = 
actin, s = supernatant, p = pellet. 
Ca'^ Ca'^/PI 
a 
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Fig. 10 (continued). 
b. Viscometry assay. After polymerization for 10 min at 25° C, the viscosities of all samples 
were measured and expressed as normalized viscosities as described in Experimental 
Procedures. 
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Fig. 10 (continued). 
c. Electron microscopy. All samples were incubated for 1 hr at 25° C and negatively stained 
as described in Experimental Procedures. (A) Pl/actin (30; 13) (arrow points to PI vesicle); 
(B) Pl/talin/actin (30:1:13) (arrows point to talin/PI complexes); (C) Ca^'^/PI/talin/actin 
(30:1:13) (B = bundle). Numbers within the parentheses are molar ratios of PI to talin and/or 
actin in the order listed. Bar = 200 nm for A and B. 
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phosphoinositides (see Fig. 10b). This suggests that phosphate groups are important for the 
talin-phosphoinositide interaction, but that other factors are involved as well. 
Discussion 
Based largely upon the in vitro talin-integrin (Horwitz et al., 1986) and talin-actin 
interactions (Muguruma et al,, 1990), together with talin's primary location at cell-matrix 
type adherens junctions (Beckerle and Yeh, 1990), Simon et al. (1991) proposed a direct 
role for talin in linking actin filaments to the cell membrane. Talin recently has been identified 
as an actin crosslinking protein (Schmidt et al., 1993), having the ability to crosslink actin 
filaments into both networks and bundles at pH 6.4 and low ionic strength (Zhang et al., 
1995). The marked pH and ionic strength dependence of the talin-actin interaction in vitro 
(Schmidt et al., 1993; Zhang et al., 1995) suggests that talin may be able to regulate actin 
filament organization in vivo at the cell-matrix attachment sites in response to specific cell 
signals. 
Talin previously has been shown to bind selectively to acidic phospholipids, such as PS, 
but not to neutral phospholipids such as PC (Heise et al., 1991). The phospholipid binding 
site(s) on talin has been located on its N-terminal 47 kDa fi-agment (Niggli et al., 1994; 
Muguruma et al., 1995), rather than on the C-terminal 190-200 kDa fi"agment containing 
talin's actin binding activity (Muguruma et al., 1990, 1995, Niggli et al., 1994). No effect of 
phospholipids on the talin-actin interaction has been reported. The phosphoinositides, 
components of eukaryotic cell membranes, have been shown to inhibit the interaction of a 
number of actin binding proteins such as profilin (Lassing and Lindberg, 1985, 1988), 
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gelsolin (Janmey and Stossel, 1987, 1989; Janmey et al., 1992), CapZ (Heiss and Cooper, 
1991), and filamin (Furuhashi et al., 1992) with actin (reviewed in Isenberg, 1991; Janmey, 
1994). The effects of the phosphoinositides, if any, on the talin-actin interaction have not 
been previously reported. 
We have used cosedimentation, viscometry, and electron microscopy analyses, and show 
for the first time that phosphoinositides including PIP2, PIP, and PI have a strongly inhibitory 
effect on the talin-actin interaction. They inhibited talin's ability to increase the viscosity of 
F-actin solutions and to crosslink actin filaments into networks and bundles at pH 6.4 and 
low ionic strength. Our results indicate the phosphoinositides interact with talin by forming 
talin/phosphoinositide complexes, and thereby prevent talin from effectively interacting with 
actin filaments. Complete inhibition of talin's ability to crosslink actin filaments was obtained 
at a molar ratio of ~ 30 phosphoinositides to 1 talin. Of the phospholipids tested herein, only 
the phosphoinositides inhibited the talin-actin interaction, showing that the interaction 
between talin and phosphoinositides is specific. The PIPjand PI were somewhat more 
effective than PIP, but all three were capable of completely inhibiting the talin-actin 
interaction. All three phosphoinositides also have been shown to inhibit interaction of cofilin 
and destrin (Yonezawa et al., 1990, 1991), filamin (Furuhashi, 1992), and severin (Eichinger 
and Schleicher, 1992) with actin. The phosphoinositide binding sites on some actin binding 
proteins have been identified, with the sites consisting of 10 to 20 amino acids, but showing 
no obvious sequence homology (Janmey et al., 1992; Yonezawa et al., 1991). These sites do 
generally contain numerous basic residues, such as lysine and arginine, suggesting 
electrostatic interaction between the head groups of the phosphoinositides and actin binding 
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proteins such as gelsolin (Janmey et al., 1992; McLaughlin, 1995), villin (Janmey et al., 
1992), and cofilin (Yonezawa et al., 1990, 1991). Further investigation will be required to 
identify the binding site(s) for phosphoinositides on talin. 
The vesicle structures of the phosphoinositides have been shov/n to be essential for their 
action on some actin binding proteins such as gelsolin (Janmey and Stossel, 1989), a-actinin 
(Fukami et al., 1992), and CapZ (Heiss and Cooper, 1991). We also showed herein that the 
vesicle structure was involved in the inhibitory effect of the phosphoinositides on the talin-
actin interaction. Preincubation of the phosphoinositides with the detergent Triton X-100 
eliminated the inhibitory effect of the phosphoinositides on talin's ability to interact with 
actin. Preincubation of the phosphoinositides with divalent cations such as Ca^"^, which 
reportedly results in the aggregation of the phosphoinositides (Janmey et al., 1989), also 
decreased ability of the phosphoinositides to inhibit the talin-actin interaction. 
The signal transduction pathway of the well described PI cycle is known to regulate a 
large array of cellular processes (Berridge, 1987; Berridge and Irvine, 1989). The 
concentration of the phosphoinositides near the cell membrane is sufficiently high 
(Rittenhouse and Sasson, 1985) to make their in vivo involvement in actin filament 
organization, via interaction with specific actin binding proteins such as talin, plausible. 
Thus, talin may function as an actin crosslinking protein at cell-matrix adherens junctions, 
and facilitate the actin filament organization/reorganization required in many cellular 
functions. 
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FUNCTIONAL COMPARISON OF PLATELET TALIN (P235) WITH SMOOTH 
MUSCLE TALIN 
A paper to be submitted to Biochemical Journal 
Jinwen Zhang 
Summary 
The abilities of purified human platelet talin (P235) and purified avian smooth muscle 
talin to interact with actin filaments were compared by using cosedimentation assays, 
viscometry assays, and electron microscopy. The results showed that platelet talin interacted 
directly with actin filaments in a fashion similar to that known for smooth muscle talin as 
follows; (1) platelet talin bound and cosedimented with actin filaments, gelated actin filament 
solutions, and crosslinked actin filaments into both networks and bundles at pH 6.4 and low 
ionic strength, (2) the interaction between platelet talin and actin was very sensitive to pH 
and ionic strength, (3) the interaction between platelet talin and actin was inhibited by 
phosphatidylinositol 4,S-bisphosphate, and (4) platelet talin was present primarily as a 
dimeric molecule under in vitro conditions in which it interacts with actin filaments. Some 
differences were noted between human platelet talin and avian smooth muscle talin, 
however, with platelet talin exhibiting lower actin crosslinking activity as measured by 
viscometry assays, and a different appearance in the actin bundles formed as observed by 
negative staining. 
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Introduction 
Talin, a protein primarily concentrated at cell-matrix attachment sites, is believed to be 
involved in linking the cytoskeleton to the cell membrane (Beckerle and Yeh, 1990), Based 
upon in vitro protein binding studies showing that talin interacts with the transmembrane 
glycoprotein integrin (Horwitz et al., 1986), with another cytoskeletal protein vinculin 
(Burridge and Mangeat, 1984), but not with actin (Burridge and Mangeat, 1984), it was 
suggested that talin is one component in a multi-protein bridge including integrin, talin, 
vinculin, a-actinin, and actin that links actin filaments to the cell membrane (Burridge et al., 
1988). More recently, a direct talin-actin interaction in vitro was found (Muguruma et al., 
1990), which led to the proposition that talin may also link actin filaments directly to the 
cytoplasmic domain of integrin at the cell membrane (Simon et al., 1991). 
At essentially the same time avian smooth muscle talin was discovered (Burridge et al., 
1982; Burridge and Connell, 1983a, b), a protein called P235 that accounts for 3-8% of total 
platelet protein was isolated from human platelets (Collier and Wang, 1982a, b). It was 
subsequently shown that talin and P235 have similar biophysical properties, one-dimensional 
peptide maps, and that they are immunologically related (O'Halloran et al., 1985; Beckerie et 
al., 1986). Both talin and P235 have the ability to interact with vinculin in vitro (O'Halloran 
et al., 1985), and both talin and P235 are cleaved in vitro by the calcium-dependent 
proteases (calpains) to yield similar fragments (Collier and Wang, 1982a; Fox et al., 1985; 
O'Halloran et al., 1985; Beckerie et al., 1986, 1987). Thus, P235 is believed to be the human 
platelet form of talin. Recent studies also have shown that the N-terminal 47 kDa fragment, 
but not the C-terminal ~ 190-200 kDa fragment of both avian smooth muscle talin 
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(Muguruma et a!., 1995) and human platelet talin (Niggli et al., 1994), contains the 
phospholipid binding site(s). Nearly all studies reported on isolated talin have been done with 
avian smooth muscle (gizzard) and/or human platelet talin. Some differences between human 
platelet talin and avian smooth muscle talin were reported. Human platelet talin has a slightly 
higher molecular mass (-235 IcDa) by SDS-PAGE (Collier and Wang, 1982a; OUalloran et 
al., 1985; Beckerle et al., 1986) than does smooth muscle talin (~ 225 kDa) (Molony et al, 
1987), suggesting different primary structures and/or post-translational modifications, such 
as glycosylation (Hagmann et al., 1992). The predicted primary structure of murine talin 
from cDNA sequence analysis revealed an estimated molecular mass of 269,854 Da, and that 
the calpain cleavage site in talin is between residues 433 and 434 (Rees et al., 1990). 
However, the cDNA sequences corresponding to human platelet talin and avian smooth 
muscle talin are not yet available for comparison. The size and shape of human platelet talin 
reported by diflFerent labs vary (Collier and Wang, 1982a, b; Goldmann et al., 1994). 
Likewise, the shape and size of avian smooth muscle talin from different labs also vary 
(Molony et al., 1987; Muguruma et al., 1992; Schmidt et al, 1993), and may be dependent 
upon factors such as ionic strength and talin concentration (Molony et al, 1987). 
Reports also have differed considerably with regard to the nature of the talin-actin 
interaction. Early reports on gizzard talin indicated no interaction v^th actin (Burridge and 
Mangeat, 1984; Beckerle and Yeh, 1990). More recently, gizzard talin has been shown to 
interact directly with actin in vitro (Muguruma et al., 1990, 1992, 1995; Goldmann and 
Isenberg, 1991; Schmidt et al, 1993; Zhang et al, 1995), although the mode of the direct 
talin-actin interaction reported varies considerably. Early reports on platelet talin indicated it 
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restricted the length of polymerizing actin filaments (Collier and Wang, 1982b). It was later 
suggested that the severing activity present in some platelet talin preparations might be due 
to the presence of severing contaminants (Burridge et al., 1990; Simon et al., 1991). 
Kaufmann et al. (1991) and Goldmann et al. (1994) have reported that platelet talin interacts 
directly with actin in vitro and nucleates actin polymerization, which results in a decrease in 
F-actin viscosity. Unless human platelet talin and smooth muscle talin are markedly different, 
it is difficult to reconcile the latter findings with those of Muguruma et al. (1990, 1992) and 
Schmidt et al. (1993), who demonstrated that smooth muscle talin increased the viscosity of 
F-actin solutions. We recently have shown that highly purified avian smooth muscle talin is 
an actin filament crosslinking protein (Schmidt et al., 1993), crosslinking actin filaments into 
both networks and bundles at pH 6,4 and low ionic strength (Zhang et al., 1995). Talin's 
actin crosslinking activity is extremely sensitive to pH and ionic strength, being enhanced by 
decrease in pH and/or ionic strength (Schmidt et al., 1993; Zhang et al., 199S), which also 
may account for some of the differences in results on talin among several labs. 
The reasons that account for the differences in talin's properties, and especially for those 
differences between human platelet talin and avian smooth muscle talin, are not clear. The 
purpose of this study was to directly compare the actin binding properties of purified human 
platelet talin and avian smooth muscle talin under identical experimental conditions. 
Experimental 
Protein Preparation - Smooth muscle talin was purified from turkey gizzards as 
described (Schmidt et al., 1993; Schmidt, 1994). Briefly, talin was extracted with a high 
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ionic strength buffer containing O.S M NaCl, and was subsequently purified sequentially on 
DEAE-cellulose, hydroxyapatite, and phosphoceltulose columns. Platelet talin was extracted 
essentially following the procedures described in Collier and Wang (1982a). Briefly, 
outdated platelets (generously provided by the Blood Bank, Mary Greeley Medical Center, 
Ames, Iowa) were pelleted, washed, and extracted with a Triton X-lOO-containing buffer 
and, then purified sequentially on DEAE-celluIose, hydroxyapatite, and phosphoceltulose 
columns as described for the smooth muscle talin. Purified smooth muscle talin and platelet 
talin were each dialyzed into the same buffer containing 10 mM imidazole, pH 7.0, 0.1 mM 
PMSF', 1 ng/ml E-64, and 0.5 mM MCE immediately before use. Actin was purified from 
porcine skeletal muscle as described (Schmidt et al., 1993; Schmidt, 1994), and was in a 
buffer containing 2 mM Tris-HCl, pH 8.0, 0.2 mM ATP, 0.2 mM CaClj, and 0.5 mM MCE. 
Protein concentrations were determined by the modified Lowry method (Sigma). 
Cosedimentation Assays - G-actin (0.50 mg/ml final concentration) was polymerized in 
the absence or presence of platelet or smooth muscle talin (0.20 mg/ml final concentration) 
in buffer A (10 mm imidazole, 1 mM ATP) at selected pH values, with pH adjustment of all 
buffers done at 25° C, by the addition of 2 mM MgClj (final concentration), or 2 mM MgCl2 
and 100 mM KCl (final concentrations). Final pH values were 6.4 or 6.9. All samples were 
incubated, centrifuged, and then analyzed by SDS-PAGE (Laemmli, 1970) as described 
'The abbreviations used are: EDC, l-ethyl-3-(3-dimethylaminopropyl) carbodiimide; MCE, 
2-mercaptoethanol; PIPj, phosphatidylinositol 4,5-bisphosphate; PMSF, 
phenylmethylsulfonyl fluoride; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis. 
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(Schmidt et al., 1993; Zhang et al., 1995). 
Low Shear Viscometry - Platelet or smooth muscle talin (0.10 mg/ml final concentration) 
was mixed with G-actin (0.25 mg/ml final concentration) in buffer A at specific pH values. 
Polymerization was then started by addition of 2 mM MgClz (final concentration). The 
viscosities of all samples were measured afler 10 min of polymerization as described 
(Schmidt et al., 1993). Results are expressed as normalized viscosity, obtained by dividing all 
talin-actin viscosity values by actin control viscosity values, and talin-actin-phospholipid 
viscosity values by actin-phospholipid control viscosity values. A value of one indicates no 
difference from controls. The phosphoinositide, PIPj, was obtained from Sigma and used in 
some experiments. The PIPj was dissolved in water, sonicated, and stored at -70° C. It was 
thawed at room temperature and sonicated for 1 min on ice immediately before use. Specific 
conditions were tested and will be stated in the Figure Legends. 
Electron Microscopy - Platelet or smooth muscle talin (0.10 mg/ml final concentration) 
was mixed with G-actin (0.25 mg/ml final concentration) in buffer A at specific pH values, 
and polymerization was induced by addition of 2 mM MgClz (final concentration). Samples 
were negatively stained and observed as described (Schmidt et al., 1993; Zhang et al., 1995). 
Chemical Crosslinking - Platelet talin (0.1 mg/ml) in buffer A containing 2 mM MgCIz at 
pH6.9 was crosslinked with EDC (20 mM final concentration). Aliquots were taken at 
specific time points, and the reaction was stopped by the addition of 20 mM glycine, 20 mM 
Tris-HCl, pH 8.0 (final concentrations). Samples were analyzed by SDS-PAGE (Laemmli, 
1970). 
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Results 
Talin Preparation - Because of the composition of the starting material (muscle vs. 
platelets), the two types of talin were extracted by different methods, with smooth muscle 
talin being extracted with a high ionic strength buffer (Schmidt et al., 1993; Schmidt, 1994), 
and platelet talin with a low ionic strength buffer containing Triton X-100 (Collier and 
Wang, 1982a). After their extraction, however, they were subjected to the same series of 
chromatographic columns. The purified talins were consistently highly homogeneous (Fig. 
1), with the only difference in purity detected being a tendency for the platelet talin to show 
more of a trace of the ~ 200 kDa C-terminal tail fragment that results from proteolysis 
(OHalloran et al., 1985; Beckerle et al., 1986). Although not obvious in the gel shown in 
Fig. 1, platelet talin migrates slightly less distance than does gizzard talin, in agreement with 
previous studies (O'Halloran et al., 1985; Beckerie et al., 1986). 
Effects ofpH and Ionic Strength on the Abilities of Platelet Talin and Smooth Muscle 
Talin to Interact with Actin Filaments - The effect of pH on the abilities of platelet and 
smooth muscle talins to cosediment with actin filaments was examined by cosedimentation 
assays (Fig. 2). At pH 6.4 and low ionic strength, a majority of the platelet talin 
cosedimented with the actin filaments (Fig. 2, panel c). At pH 6.9, however, much less 
platelet talin cosedimented with the actin filaments (Fig. 2, panel f). Qualitatively similar 
results to those obtained with platelet talin were obtained with smooth muscle talin at pH 6.4 
and 6.9 (Fig. 2, panels i and 1, respectively). Similar results with smooth muscle talin have 
been shown previously (Schmidt et al., 1993), There was slightly more platelet talin than 
smooth muscle talin left in the supematants (s) of the talin/actin mixtures at pH 6.4 (cf, Fig. 
I 
Fig. 1. Purifled smooth muscle talin and platelet talin analyzed by SDS-PAGE. Lane 1, 
avian smooth muscle talin; lane 2, human platelet talin (P235). 

Fig. 2. Eflect of pH on the abilities of platelet and smooth muscle talins to cosediment 
with F-actin. Actin (0.25 mg/ml final concentration) was polymerized in the absence or 
presence of platelet or smooth muscle talin (0.10 mg/ml final concentration) by the addition 
of 2 mM MgCl2 (final concentration) at pH 6.4 or 6.9. Samples were incubated, centrifijged, 
and analyzed as described in Experimental, (a) actin control at pH 6.4; (b) platelet talin 
control at pH 6.4; (c) actin/platelet talin at pH 6.4; (d) actin control at pH 6.9; (e) platelet 
talin control at pH 6.9; (f) actin/platelet talin at pH 6.9; (g) actin control at pH 6.4; (h) 
smooth muscle talin control at pH 6.4; (i) actin/smooth muscle talin at pH 6.4; (j) actin 
control at pH 6.9; (k) smooth muscle talin control at pH 6,9; (1) actin/smooth muscle talin at 
pH 6.9. s = supernatant, p = pellet, T = talin, A = actin. 
platelet talin smooth muscle talin 
pH 6.4 pH 6.9 pH 6.4 pH 6.9 
a b c  d e  f  g h i  1  i c  T  
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2, panels c with i), and slightly less platelet talin than smooth muscle talin cosedimented with 
F-actin in the pellets (p) of talin/actin mixtures at pH 6.9 (Fig. 2, of., panels f with 1), which 
indicate that, under the same ionic conditions, smooth muscle talin bound to F-actin slightly 
stronger than did platelet talin. 
The effect of pH on the abilities of platelet and smooth muscle talins to increase the 
viscosity of F-actin solutions was examined by low shear viscometry assay (Fig. 3). At pH 
6.4 and low ionic strength, both platelet and smooth muscle talins dramatically increased the 
viscosity of F-actin solutions and effectively "gelated" the F-actin solutions (i.e., the ball 
would not roll through the viscous solutions) (Fig. 3). As pH was increased to 6.9, both of 
the talins' abilities to increase the viscosity of F-actin solutions decreased as expected 
(Schmidt et al., 1993), with smooth muscle talin retaining stronger crosslinking activity than 
did platelet talin. At pH 7.3, the abilities of both smooth muscle and platelet talins to 
increase the viscosity of F-actin solutions decreased further, with values approaching those 
of the control actin (results not shown). Neither platelet nor smooth muscle talin exhibited 
any ability, under any conditions tested, to decrease the viscosity of actin solutions in our 
studies. 
The nature of the interaction between platelet and smooth muscle talins and actin 
filaments was examined by electron microscopy (Fig. 4). At pH 6.4 or pH 6.9, and low ionic 
strength, the control actin filaments were randomly dispersed (Fig. 4A and 4D, respectively). 
At pH 6.4 and low ionic strength, smooth muscle talin crosslinked actin filaments into both 
networks (NW) and bundles (B) (Fig, 4B) as we have shown previously (Zhang et al., 
1995). As shown in Fig. 4C, platelet talin also crosslinked actin filaments into networks 
Fig. 3. EfTect of pH on the abilities of platelet and smooth muscle talins to increase the 
viscosity of F-actin solutions. Actin (0.25 mg/ml final concentration) was polymerized in 
the absence or presence of platelet or smooth muscle talin (0.10 mg/ml final concentration) 
by addition of 2 mM MgCl2 (final concentration) at pH 6.4 or 6.9. The viscosities of all 
samples vs^ere measured as described in Experimental, gel = gelated actin (i.e., ball stopped). 
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Fig. 4. Effect of pH on the abilities of platelet and smooth muscle talins to crosslink 
actin filaments as shown by electron microscopy. Actin (0.25 mg/ml final concentration) 
was polymerized in the absence or presence of platelet or smooth muscle talin (0.10 mg/ml 
final concentration) by addition of 2 mM MgClj (final concentration) at pH 6.4 or 6.9. 
Samples were then negatively stained as described in Experimental. (A) actin filament 
control at pH 6,4; (B) actin/smooth muscle talin at pH 6.4; (C) actin/platelet talin at pH 6.4; 
(D) actin filament control at pH 6.9; (E) actin/smooth muscle talin at pH 6.9; (F) 
actin/platelet talin at pH 6.9. Single arrows in C and F point to structures described in the 
text. NW = network, B = bundle; Bar = 100 nm for A-F. 
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(NW), but bundles similar to those formed by smooth muscle talin (Fig. 4B) were not seen. 
Instead, the platelet talin-rich actin bundles observed have aggregates of talin associated with 
the actin filaments in a discontinuous pattern (Fig. 4C), rather than uniformly as along the 
more ordered bundles observed with smooth muscle talin (Fig. 4B). At pH 6.9, smooth 
muscle talin's ability to crosslink actin filaments decreased, as shown by the presence of 
fewer and smaller bundles than at pH 6.4 (cf Fig. 4E with Fig. 4B). At pH 6.9, platelet talin 
retained ability to crosslink actin filaments into networks (NW), but fewer talin aggregates 
were associated with actin filaments to form talin-rich actin bundle-like structures than at pH 
6.4 (cf, Fig. 4F with Fig. 4C). Smooth muscle talin retained more pronounced bundling 
activity than did platelet talin at pH 6.9 (cf, Fig. 4E with 4F). 
The effect of ionic strength on the interaction between platelet talin and actin was 
examined by cosedimentation assays (Fig. 5). In the presence of 100 mM KCl, platelet talin 
lost its ability to cosediment with actin filaments at pH 6.4 (cf, Fig.5, panel c with Fig. 2, 
panel c). Schmidt (1994) showed that smooth muscle talin's ability to cosediment with F-
actin at pH 6.4 in the presence of 100 mM KCl also was considerably decreased in 
comparison to pH 6.4 and no KCl, but a small amount (~ 20%) of the smooth muscle talin 
still was found in the F-actin pellet. 
The results of viscometry assays (Fig. 6) are in concert with the cosedimentation assays 
(Fig. 5). As shown in Fig. 6, with increasing concentration of KCl, both smooth muscle and 
platelet talins' abilities to increase the viscosity of F-actin solutions decreased, with smooth 
muscle talin retaining stronger ability than platelet talin to increase the viscosity of F-actin 
solutions. Neither of the talins decreased the low shear viscosity of F-actin below that of F-
Fig. 5. EfTect of ionic strength on the ability of platelet talin to cosediment with F-actin 
at pH 6.4. Actin (0.25 mg/ml final concentration) was polymerized in the absence or 
presence of platelet talin (0.10 mg/ml final concentration) by the addition of 2 mM MgClj 
and 100 mMKCl (final concentrations) at pH 6,4. Samples were incubated, centrifiiged, and 
analyzed as described in Experimental, (a) actin control; (b) platelet talin control; (c) 
actin/platelet talin. s = supernatant, p = pellet, A = actin, P235 = platelet talin. 
100 mM KCl 
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Fig. 6.  Effect of ionic strength on the abilities of platelet and smooth muscle talins to 
increase the viscosity of F-actin solutions at pH 6.4. Actin (0.2S mg/ml final 
concentration) was polymerized in the absence or presence of platelet or smooth muscle 
talin (0.10 mg/ml final concentration) by the addition of 2 mM MgClz (final concentration) 
and selected concentrations of KCl at pH 6.4. Samples were incubated and the viscosities of 
all samples were measured and expressed as normalized viscosities as described in 
Experimental. 
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actin controls, regardless of the ionic strength tested (results not shown). 
The Effect of Phosphaticfylinositol 4,5-bisphosphate on the Talin-Actin Interaction -
The effects of PIP2 on the interaction of platelet and smooth muscle talins with actin 
filaments were compared by viscometry assays. As shown in Fig. 7, the interaction between 
each type of talin and actin was inhibited by PIPj. However, smooth muscle talin appeared to 
be more sensitive to inhibition of its ability to increase the low shear viscosity of F-actin by 
PIP2 than was platelet talin. Both talins lost their ability to increase the viscosity of F-actin 
solutions at a molar ratio of ~ 30 PPj to one talin. 
Chemical Crosslinking of Platelet Talin - Recent studies have suggested that smooth 
muscle talin functions as a dimeric molecule (i.e., two subunits in the native molecule) 
(Muguruma et al., 1992, 1995; Zhang et al., 1995) as also suggested for platelet talin 
(Goldmann et al., 1994). Our crosslinking results obtained with the zero-length chemical 
crosslinking reagent, EDC are shown in Fig. 8. With increasing crosslinking time at pH 6.9 
and low ionic strength, the amount of a band corresponding to an approximately 400 kDa 
protein increased, concomitantly with a decrease in the amount of the monomer band of 
platelet talin. Thus, platelet talin was present as a dimer, a result in agreement with that 
obtained with platelet talin by Goldmann et al. ( 1994), and similar to what we obtained with 
smooth muscle talin (Zhang et al., 1995). 
Discussion 
We used the same series of chromatographic columns to purify both the platelet and 
smooth muscle talins, and obtained highly homogenous samples of proteins. We then 
Fig. 7. Eflect of the phosphoinositide PIPj on the abilities of platelet and smooth 
muscle talins to increase the viscosity of F-actin solutions at pH 6.4. Platelet or smooth 
muscle talin (0,10 mg/ml final concentration) was incubated with phosphatidylinositol 4,5-
bisphosphate (PIP2) for 30 min at 25° C before G-actin (0.25 mg/ml final concentration) was 
added, and polymerization started by the addition of 2 mM MgCl2 (final concentration). The 
viscosities of all samples were measured and expressed as normalized viscosities as described 
in Experimental. 
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Fig. 8. Chemical crosslinking of platelet talin by EDC. Platelet talin (0.1 mg/ml final 
concentration) in buffer A containing 2 mM MgClj at pH 6.9 was crosslinked with EDC (20 
mM final concentration). Aliquots of the reaction mixture were taken at specific time points, 
quenched, and analyzed by SDS-PAGE. Lane 1, talin before addition of EDC; lanes b, c, d, 
e, and f are after addition of EDC and represent 10, 30, 60, 120, and 240 min of 
crosslinking, respectively. Numbers to the right of the gel correspond to the molecular mass 
(kDa) of protein standards in lane g. M = talin monomer, D = talin dimer corresponding an 
~ 400 kDa protein. 
a b c d e f g 
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compared, under the same sets of experimental conditions, the abilities of human platelet and 
smooth muscle talins to interact with actin by using cosedimentation and viscometry assays, 
and electron microscopy. In general, the results showed that platelet talin interacted with 
actin in a fashion similar to that obtained with smooth muscle talin. At pH 6.4 and low ionic 
strength, both proteins cosedimented with actin filaments, markedly increased the viscosity 
of F-actin solutions, and crosslinked actin filaments as shown by negative staining. 
Furthermore, the abilities of both proteins to interact with actin were very sensitive to pH 
and/or ionic strength, being decreased with increase in pH and/or ionic strength. The abilities 
of both types of talin to interact with actin were effectively eliminated by their interaction 
with PIP2. 
The results of the cosedimentation and viscometiy assays obtained herein, with both 
talins, are similar to those obtained with avian smooth muscle talin by Muguruma and 
associates (Muguruma et al., 1990, 1992, 1995) and by Schmidt et al. (1993) and Zhang et 
al. (1995) in our lab, but are different from those obtained with human platelet talin by 
Isenberg and associates (Kaufmann et al., 1991; Goldmann et al., 1994). Kaufmann et al. 
(1991) and Goldmann et al. (1994) reported a platelet talin-induced decrease in the viscosity 
of F-actin solutions, and suggested that the decrease in actin viscosity, especially at short 
polymerization times, resulted from an increase in number of actin filaments but decrease in 
their length. We did not observe any decrease in F-actin viscosity as a result of addition of 
either platelet or smooth muscle talin under any experimental conditions. And, we measured 
the low shear viscosity after only 10 minutes of polymerization. Thus, these diflfering results 
obtained by different labs seem unlikely to be due primarily to functional differences between 
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human platelet talin and avian smooth muscle talin. The reason for platelet talin's actin 
viscosity-reducing activity (Kaufmann et a!., 1991; Goldmann et al., 1994) may be the purity 
of the talin used. Those investigators used a rather high molar ratio of talin to actin (~ one 
talin to two actins), which can increase the problem with even a small amount of 
contaminants having either potent nucleating, capping, or severing activity. Our lab showed, 
for instance, that actin binding contaminants in conventionally purified preparations of 
vinculin significantly decreased the low shear viscosity of F-actin solutions (Evans et al., 
1984). Interestingly, others have reported (Burridge et al., 1990; Simon et a!., 1991) that an 
actin severing contaminant(s) can be removed from human platelet talin prepared by 
procedures similar to those described in Kaufmann et al. (1991) and Goldmann et al. (1994). 
The differences observed herein that avian smooth muscle talin possesses somewhat 
stronger actin crosslinking activity than platelet talin under the same ionic conditions, and 
the different appearance of the actin bundle-like structures formed in the presence of platelet 
talin in comparison to the more highly ordered actin bundles formed in the presence of 
smooth muscle talin, may be related to different molecular properties of the two talins. 
Human platelet talin migrates slightly slower than avian smooth muscle talin by SDS-PAGE 
(OUalloran et al., 1985; Beckerle et al., 1986), suggesting different primary structure/size 
and/or post-translational modifications. No sequence information for the two talins is yet 
available for comparison. One report (Hagmann et al., 1992) indicated that a small 
proportion of smooth muscle talin, but none of the platelet talin, is glycosylated. 
Unfortunately, most primary structure data are derived from analysis of cDNA sequence, 
and the type and degree of post-translational modification in the two talins may not become 
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available for some time. In cells grown in culture, talin is found together with vinculin in 
focal adhesions (Burridge and Connell 19g3a; Burridge et al., 1988). In adult smooth muscle 
cells, talin is primarily localized at the analogous membrane-associated dense bodies 
(Volberg et al., 1986). In resting platelets, however, talin is absent from the vinculin-rich 
areas at the ends of stress fibers near the cell membrane (Nachmias and Golla, 1991) and 
instead has a uniform, cytoplasmic distribution (Beckerle et al., 1989). The distribution of 
talin in platelets changes dramatically when platelets are activated to become adhesive, as the 
talin is translocated to a peripheral submembrane location (Beckerle et al., 1989). These 
functional differences between smooth muscle talin and platelet talin suggest the possibility 
of some differing molecular properties of the two proteins. 
Heise et al. (1991) have shown that talin binds acidic phospholipids such as 
phosphatidylserine, and the phospholipid binding sites have been located on talin's N-
terminal ~ 47 kDa fragment (Niggli et al., 1994; Muguruma et al., 1995), No evidence, 
however, for an effect of any of the phospholipids on the talin-actin interaction has been 
reported. The phosphoinositides have been shown to inhibit the interaction of a number of 
actin binding proteins with actin (Isenberg, 1991; Janmey, 1994). We have shown in this 
study, by using low shear viscometry assays, that the phosphoinositide PIPj inhibits the 
abilities of both platelet and smooth muscle talins to increase the viscosity of F-actin 
solutions at pH 6.4 and low ionic strength. The results suggest that the actin binding 
activities of both platelet and smooth muscle talins may be regulated in a similar fashion by 
phosphoinositides. 
Overall, the results of this study indicate that human platelet talin and avian smooth 
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muscle talin share many similarities in their abilities to interact with actin, but that some 
differences remain. 
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OVERALL SUMMARY 
The major objectives of my dissertation studies were to (1) determine the structural basis 
for the effect of pH and ionic strength on the talin-actin interaction, (2) examine the effects 
of other factors, including specific phospholipids, on the talin-actin interaction, and (3) 
compare abilities of human platelet and smooth muscle talins to interact with actin. In the 
first and second chapters included herein, I used cosedimentation assays, electron 
microscopy, and chemical crosslinking experiments to examine the structural basis for the 
pH and ionic strength dependence of the talin-actin interaction. The major findings from the 
results of these experiments are as follows; 
(1) At pH 6.4 and low ionic strength, talin extensively crosslinked actin filaments into 
both networks of intermeshed filaments and bundles. The bundles consist of parallel actin 
filaments with a center-to-center filament spacing of ~ 13 nm, and talin crossbridges 
positioned at ~ 36 nm intervals along the actin bundles. As the pH was increased from 6.4 to 
7.3, talin's bundling activity was first decreased, then its networking activity, vwth both 
activities nearly absent at pH 7.3. The talin-actin interaction also was very sensitive to ionic 
strength. Talin's actin bundling activity at pH 6.4 was dramatically decreased when the ionic 
strength was increased by adding as little as 25 mM KCl to the protein solution, and 
disappeared with 75 mM KCl present, with only its networking activity remaining. The 
results show that talin can interact directly with actin filaments by formation of actin filament 
networks and bundles, with the bundles more sensitive to dissolution by increase in pH 
and/or ionic strength. 
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(2) Talin was present primarily as a dimeric molecule at pH 6.4 to 7.3, with or without 
100 mM KCl present. These results show that talin's ability to self-associate is not noticeably 
pH or ionic strength dependent, indicating that the effect of pH or ionic strength on the talin-
actin interaction appears due to the direct talin-actin interaction rather than the self-
association of talin. 
(3) Talin's ability to crosslink actin filaments was not noticeably affected by the length of 
polymerization time. Even with a short, five minute polymerization time, talin crosslinked 
actin filaments into both networks and bundles, without noticeably restricting the length of 
actin filaments in comparison to control F-actin. 
(4) Talin was able to crosslink preformed actin filaments into both networks and bundles 
as well as it did when actin was polymerized in its presence. 
(5) Talin's ~ 190kDa C-terminal tail fragment had the ability to crosslink actin filaments 
into both networks and bundles. However, it required a slightly lower pH than did intact 
talin. 
The major objective of the third chapter of my dissertation was to examine the effect of 
specific phospholipids, especially phosphoinositides, on the talin-actin interaction by using 
cosedimentation assays, low shear viscometry assays, and electron microscopy. The major 
findings obtained from the results in this chapter are as follows; 
(1) The three phosphoinositides, phosphatidylinositol 4.5-bisphosphate (PIP2), 
phosphatidylinositol 4-phosphate (PIP), and phosphatidylinositol (PI), when incubated with 
talin (molar ratio of ~ 30 phosphoinositides to one talin) prior to its addition to actin and 
polymerization, effectively inhibited the ability of talin to crosslink actin filaments into both 
153 
networks and bundles at pH 6.4 and low ionic strength. Phosphoinositides affected the talin-
actin interaction by interacting with talin, but not actin, by forming talin/phosphoinositide 
complexes, which in turn prevented talin from effectively interacting with actin filaments. 
(2) The presence of phosphatidylserine (PS), phosphatidylcholine (PC), and inositol 
l,4,S-trisphosphate (IP3) under the same ionic conditions did not affect the talin-actin 
interaction. 
(3) The presence of G-actin during the talin-phosphoinositide preincubation period did 
not affect the interaction between talin and phosphoinositides. 
(4) The inhibitory effect of phosphoinositides on the talin-actin interaction was 
eliminated by preincubating phosphoinositides with the detergent Triton X-100, suggesting 
that phosphoinositide vesicles are necessary for their inhibitory effects. The inhibitory effect 
of phosphoinositides on the talin-actin interaction also was decreased by preincubation with 
divalent cations such as Ca^^. 
The major objective of the fourth chapter in my dissertation was to compare the abilities 
of purified human platelet and avian smooth muscle talins to interact with actin filaments, 
under the same experimental conditions, by using cosedimentation assays, low shear 
viscometry assays, and electron microscopy. The major findings obtained from the results in 
this chapter are as follows; 
(1) Highly homogeneous human platelet talin and avian smooth muscle talin were 
obtained by following similar preparation procedures. 
(2) Platelet talin (P23S) interacted with actin filaments in a manner similar to that of 
smooth muscle talin. At pH 6.4 and low ionic strength, both talins bound and cosedimented 
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with actin filaments, dramatically increased the viscosity of F-actin solutions, and crosslinked 
actin filaments into networks and bundles. As pH and/or ionic strength was increased, 
platelet talin's ability to crosslink actin filaments decreased as also was observed for smooth 
muscle talin. 
(4) The interaction of platelet or smooth muscle talin with actin was inhibited by PIP2. 
(5) Some differences were detected between platelet and smooth muscle talins, with 
smooth muscle talin exhibiting a stronger actin crosslinking activity, and platelet talin 
crosslinking actin filaments into bundle-like structures that appeared different than the more 
highly ordered actin bundles obtained with smooth muscle talin. 
Overall, the results presented in my dissertation provide a structural explanation for the 
reported talin-actin interaction, in which talin directly binds to actin filaments and increases 
the viscosity ofF-actin solutions (Muguruma, et al., 1990; 1992; Schmidt et al., 1993). I 
have shown that talin crosslinks actin filaments into both networks and bundles at pH 6.4 
and low ionic strength. These results suggest that talin may function as an actin crosslinking 
protein at cell-matrix adherens junctions, and thereby facilitate the actin filament 
organization/reorganization required in many cellular functions. 
My results do not support the reports that platelet talin decreases the viscosity of actin 
solutions, especially at short polymerization times, by increasing the number of actin 
filaments and decreasing their length (Kaufmann et al., 1991; Goldmann et al., 1994). The 
results presented herein showed that after only a five minute-polymerization talin crosslinked 
actin filaments into networks and bundles, without showing a significant number of shorter 
actin filaments in comparison to the actin controls. I also compared the abilities of human 
platelet and avian smooth muscle talins to interact with actin under the same experimental 
conditions. These results showed that human platelet talin behaved in an overall fashion 
similar to that of smooth muscle talin, but with some differences noted. One possibility for 
some of the differences in the talin-actin interaction reported by different labs is the degree 
of purity of the talin used. Burridge et al. (1990) and Simon and Burridge (1994) have noted 
that actin severing contaminants are present in some platelet talin preparations. Another 
possibility for some of the differences in the talin-actin interaction reported from different 
labs is the marked sensitivity of the talin-actin interaction that I observed. Even rather small 
differences in experimental conditions can significantly influence the results. 
My studies also showed for the first time that talin interacts with phosphoinositides. 
These results open up an entirely new avenue with regard to how talin may interact with 
actin or other talin binding proteins in cells. 
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